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Cell fate reprogramming is transforming our understanding of the establishment and 
maintenance of cellular identity. In addition, reprogramming holds great promise to model 
diseases affecting cell types that are prohibitively difficult to study, such as human neurons. 
Overexpression of the brain-enriched microRNAs (miRNAs), miR-9/9* and miR-124 (miR-
9/9*-124) results in reprogramming human somatic cells into neurons and has recently been used 
to generate specific neuronal subtypes affected in neurodegenerative disorders. However, the 
mechanisms governing the ability of miR-9/9*-124 to generate alternative subtypes of neurons 
remained unknown. In this thesis, I report that overexpressing miR-9/9*-124 triggers 
reconfiguration of chromatin accessibility, DNA methylation, and mRNA expression to induce a 
default neuronal state. MiR-9/9*-124-induced neurons (miNs) are functionally excitable and are 
uncommitted towards specific subtypes yet possess open chromatin at neuronal subtype-specific 
loci, suggesting such identity can be imparted by additional lineage-specific transcription factors. 
Consistently, we show ISL1 and LHX3 selectively drive conversion to a highly homogenous 
population of human spinal cord motor neurons. This work shows that modular synergism 
xi 
 
between miRNAs and neuronal subtype-specific transcription factors can drive lineage-specific 
neuronal reprogramming, thereby providing a general platform for high-efficiency generation of 
distinct subtypes of human neurons. 
Since many neurodegenerative diseases occur after development, modeling them requires 
reprogramming methods capable of generating functionally mature neurons. However, few 
robust molecular hallmarks existed to identify such neurons, or to compare efficiencies between 
reprogramming methods. Recent studies demonstrated that active long genes (>100 kb from 
transcription start to end) are highly enriched in neurons, which provided an opportunity to 
identify neurons based on the expression of these long genes. We therefore worked to develop an 
R package, LONGO, to analyze gene expression based on gene length. We developed a 
systematic analysis of long gene expression (LGE) in RNA-seq or microarray data to enable 
validation of neuronal identity at the single-cell and population levels. By combining this 
conceptual advancement and statistical tool in a user-friendly and interactive software package, 
we intended to encourage and simplify further investigation into LGE, particularly as it applies 
to validating and improving neuronal differentiation and reprogramming methodologies. Using 
this tool, I found by single-cell RNA sequencing that microRNA-mediated neuronal 
reprogramming of human adult fibroblasts yields a homogenous population of mature neurons, 
and that LGE distinguishes mature from immature neurons. I found that LGE correlates with 
expression of neuronal subunits of the Swi/Snf-like (BAF) chromatin remodeling complex, such 
as ACTL6B/BAF53b. Finally, I found that the loss of a functional neuronal BAF complex, as 
well as chemical inhibition of topoisomerase I, decreases LGE and reduces spontaneous 
electrical activity. Together, these results provide mechanistic insights into microRNA-mediated 
neuronal reprogramming, and demonstrate a transcriptomic feature of functionally mature 
xii 
 
neurons. 
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Understanding genetic pathways that specify neuronal cell fates during development 
has enabled directed differentiation of pluripotent stem cells to specific neuronal subtypes 
(Perrier et al., 2004; Wichterle et al., 2002). This knowledge has been further leveraged to 
directly convert (or reprogram) non-neuronal somatic cells into neurons via ectopic 
expression of pro-neural transcription factors (TFs) or neurogenic miRNAs with TFs 
(Mertens et al., 2016). These direct conversion modalities may prove invaluable in the study 
of late-onset neurodegenerative diseases, as the original age of human fibroblasts is 
maintained in converted neurons (Huh et al., 2016; Mertens et al., 2015) in contrast to the 
cellular rejuvenation observed in induced pluripotent stem cells (Horvath, 2013; Miller et 
al., 2013). Interestingly, the miRNA-mediated reprogramming approach can achieve high 
conversion efficiency in adult human fibroblasts, which may provide unique opportunities 
in modeling neurological disorders using patient-derived neurons (Victor et al., 2014). 
However, despite the advantages of direct reprogramming, little is known about the 
epigenetic and molecular events that accompany direct cell-fate conversion. 
MiRNAs regulate genetic pathways by binding to their target transcripts and 
repressing their expression (Pasquinelli, 2012). Target specificity is governed largely 
through short sequence complementarity within the 5’ end of a miRNA enabling a single 
miRNA to target hundreds of mRNA transcripts (Boudreau et al., 2014; Chi et al., 2009). 
Moreover, a single mRNA can be targeted by multiple miRNAs, markedly enlarging the 
effect on single gene repression (Wu et al., 2010). The convergence of genetic controls by 
miRNAs towards a specific biological process is exemplified by miR-9/9* and miR-124 
miRNAs activated at the onset of neurogenesis (Conaco et al., 2006; Makeyev et al., 2007). 
For example, miR-9* and miR-124 synergistically initiate subunit switching within BAF 
chromatin remodeling complexes (Staahl et al., 2013; Yoo et al., 2009) while separately 
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repressing the neuronal cell-fate inhibitors REST, Co-REST and SCP1 (Packer et al., 2008; 
Visvanathan et al., 2007). These examples suggest that miR-9/9* and miR-124 target 
components of genetic pathways that antagonize neurogenesis to promote a neuronal 
identity during development.  
Co-expressing miR-9/9* and miR-124 (miR-9/9*-124), with TFs enriched in the 
cortex and striatum directly converts primary adult human fibroblasts to cortical and striatal 
medium spiny neurons, respectively (Yoo et al., 2011; Victor et al., 2014). However, the 
same TFs without miR-9/9*-124 fail to trigger neuronal conversion (Victor et al., 2014; 
Yoo et al., 2011), suggesting that the miRNA-induced neuronal state is permissive to 
terminal selector TFs which, upon determination of a neuronal fate, initiate and advance 
mature subtype-identities (Stefanakis et al., 2015). 
In my thesis work, my colleagues and I systematically investigated a miRNA-
induced neuronal state in adult human cells. Longitudinal analyses of the transcriptome, 
genome-wide DNA-methylation and chromatin accessibilities revealed that miR-9/9*-124 
induced extensive remodeling of the epigenome, including simultaneous activation of a pan-
neuronal program and the reconfiguration of chromatin accessibilities. These changes 
precede the emergence of differentially methylated genomic regions. Because miR-9/9*-
124 also led to the opening of genomic loci for multiple subtype-specific genes including 
established motor neuron markers, we postulated that motor neuron-enriched transcription 
factors would cooperate with miR-9/9*-124 to specify a motor neuron lineage. As such, we 
demonstrate that co-expressing TFs ISL1 and LHX3 along with miR-9/9*-124 generated a 
highly pure population of human spinal cord motor neurons. Taken together, these results 
demonstrate that miR-9/9*-124 opens the neurogenic potential of adult human fibroblasts 
and provides a platform for subtype-specific neuronal conversion of human cells. 
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With the growing interest in advancing these reprogramming methods, there is a 
need to determine efficiencies and compare outcomes across different methods. However, 
these efforts are hindered by the lack of reliable measures for neuronal identity. Electrical 
activity, one hallmark of neurons, is typically only measured in a handful of cells in a given 
experiment and can be biased, as cells targeted for analysis may not be representative of the 
entire population. Expression of a small subset of neuronal proteins measured by 
immunocytochemistry (ICC) is also used to mark neuronal identity but is often subjective 
and highly variable. Furthermore, interpretation of ICC is unreliable, given that extrinsic 
factors used during neuronal reprogramming may selectively increase the expression of 
several neuronal genes without necessarily resulting in complete cell-fate transition. Whole 
transcriptome data has potential to overcome these limitations, and several complex 
computational approaches such as iterative principal component analysis (PCA) and 
iterative weighted gene co-expression network analysis (WGCNA) have been successful in 
classifying cell types (Tasic, et al., 2016). However, these methods require a positive 
control and at least 15 samples for accuracy. A simpler and more easily assessable measure 
of neuronal identity at the transcriptome level would greatly facilitate the development and 
validation of neuronal reprogramming methods.  
Recent studies have shown that long genes (>100 kb from transcription start to end) 
are selectively expressed in neurons (Gabel, et al., 2015; King, et al., 2013; Sugino, et al., 
2014). This unique feature of neurons may provide an opportunity to utilize measurements 
of long gene expression (LGE) in transcriptome data to distinguish neurons from non-
neuronal cells quickly and easily. In my thesis work, I helped developed LONGO 
(https://github.com/biohpc/longo) (an open source computational package based in R with 
the interactive web-supporting library, R-Shiny) to standardize measurement of LGE within 
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RNA-seq and microarray data formats. By providing an interactive and convenient analysis 
of LGE within transcriptome data, LONGO allows researchers to identify neurons, and to 
explore gene ontology (GO) terms associated with enriched neuronal genes. Additionally, 
by applying LGE analysis to single-cell RNA-seq of microRNA-mediated neuronal 
reprogramming, I found that the onset of LGE correlates with subunit switching of the BAF 
chromatin remodeling complex. This same subunit switching can be observed during 
differentiation of neurons from neural progenitor cells, a process which, significantly, is 
controlled by the expression of miR-9/9* and miR-124 in vertebrates (Yoo, et al., 2009). I 
also show that disrupting the functional BAF complex decreases LGE, which results in less 
spontaneous electrical activity. Together, this work demonstrates that LGE distinguishes 
fully differentiated and functionally mature neurons from immature neurons and non-
neuronal cells, which will allow for the innovation and improvement of neuronal 
reprogramming and differentiation methods to model human disease. 
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Specific Reprogramming of Adult Human 
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Ouwenga, Xiaoyun Xing, Daofeng Li, Hyung Joo Lee, Robert O. Heuckeroth, Joseph D. 
Dougherty, Ting Wang, Andrew S. Yoo 
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2.1 Results 
2.1.1 Neuronal Conversion of Human Adult Fibroblasts With miR-9/9*-
124 Alone 
To dissect how miRNAs alone contribute to neuronal conversion, we first tested the 
ability of miR-9/9*-124 to convert primary human fibroblasts collected from multiple adult 
individuals from ages 22 to 68 into microRNAs-induced neurons (miNs). We transduced 
fibroblasts with lentivirus containing a doxycycline (Dox)-inducible promoter driving miR-
9/9*-124 and BCL-XL expression (Victor et al., 2014) (Figures 1A and S1A). At 35 days 
post-transduction, we evaluated cell morphology and the expression of neuronal markers 
MAP2, TUBB3 and NEUN by immunocytochemistry (Figure 1B). Strikingly, miR-9/9*-
124 alone converted 80% of the fibroblasts to neuronal cells displaying complex neurite 
outgrowth and neuronal marker expression (Figures 1B and 1C). The converted cells 
stained positive for voltage-gated sodium channels SCN1A and Ankyrin G, which localized 
at axonal initial segments with a characteristic polarized staining pattern (Figure 1D). The 
synaptic vesicle marker SV2 displayed defined puncta along neurites, consistent with the 
adoption of a neuronal fate (Figure 1D). 
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Fig. 1. Direct Conversion of Young and Old Primary Adult Human 
Fibroblasts into Neurons via miRNA Overexpression. 
(A) Experimental scheme for miR-9/9*-124 mediated direct neuronal conversion. (B) Adult 
human fibroblasts ectopically expressing miR-9/9*-124 for 35 days immunostained for the 
pan-neuronal markers TUBB3, MAP2 and NEUN. Insets represent starting fibroblasts co-
stained as negative controls. Scale bars = 20m. (C) Quantification of TUBB3, MAP2 and 
NEUN positive cells over total number of cells (DAPI). For TUBB3 and MAP2, only cells 
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with processes at least three times the length of the soma were counted. For NEUN, only 
cells with proper nuclear localization were counted. Data are represented as mean ± SEM. 
22 Yr Female n = 238 cells, 42 Yr Female, n = 100 cells, 56 Yr Male n = 171 cells, and 68 
Yr Female n = 216. (D) Converted neurons display hallmark sodium channel (SCN1A), 
axonal initial segment (ANKG) (left) and synaptic vesicle (SV2) (right) staining patterns. 
Scale bars = 20m. (E) Representative traces of TTX-sensitive inward and potassium 
whole-cell currents. (F) Repetitive AP waveforms in response to 500 ms current injections 
recorded from converted neurons in monoculture. (G) Summary of AP firing patterns 
observed in 23 neurons recorded in current-clamp mode (left) and representative waveforms 
within each firing pattern recorded (right). See also Figure S1. 
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2.1.2 Functional Properties and Stability of miNs  
To determine if miNs displayed membrane excitability, we performed whole-cell 
recording on miNs without glial co-culture. All cells recorded (23/23 cells) exhibited fast 
TTX-sensitive inward currents upon depolarization (Figure 1E), while 19/23 cells fired 
action potentials (APs) during current injections (9 cells with multiple APs and 10 with 
single APs) (Figures 1F and 1G). Similar current (I)-voltage (V) curve relationships were 
observed between cells that fired multiple or single APs (Figure S1B). All miNs had stable 
hyperpolarized resting membrane potentials ranging from -52.7 to -84.5 mV with a mean 
value of -69.63 mV ± 2.15 mV (S.E.M.) (Figures S1C and S1D). There was no correlation 
between capacitance and firing patterns suggesting this membrane property is not as an 
accurate measure of neuronal maturation (Figure S1E). Together, this data indicates that 
miNs exhibit the membrane functionality of neurons. 
The minimum duration of miRNA expression required for neuronal conversion was 
determined by inactivating the Dox-inducible promoter at 3-day intervals by Dox removal 
beginning at day 9 until reprogramming day 30 (Figure S1F). Loss of fibroblast identity and 
gain of neuronal identity was assayed by analyzing fibroblast-specific protein (FSP1) and 
MAP2 expression, respectively. Surprisingly, we saw a reduction in the number of FSP1-
positive cells and the appearance of MAP2-positive cells after only 9 days of miRNA 
expression. However, effective switching of a cell population from FSP1- to MAP2-positive 
cells required 30 days of miR-9/9*-124 expression (Figure S1F). These data reveal the non-
synchronous process of the neuronal conversion and temporal requirements for highly 
efficient neuronal conversion. The stability of miRNA-induced neuronal conversion was 
determined by following miNs for an additional 30 days after removing miR-9/9*-124 
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exposure (Figure S1G, top). The majority of miNs remained as post-mitotic neurons 
(marked by the absence of Ki67, a cell proliferation marker) expressing MAP2, TUBB3, 
NeuN and NCAM, in contrast to non-converted fibroblasts (Figure S1G, left panel), 
indicating that the morphological and protein expression changes that accompany miR-
9/9*-124-mediated conversion of adult human fibroblasts are stable after 30 days of miR-
9/9*-124 expression. 
2.1.3 Transcriptional Profiling of miNs 
To further explore the miR-9/9*-124-mediated neuronal output, we profiled the 
transcriptome of starting human adult fibroblasts and miNs by RNA-Seq after 30 days of 
neuronal conversion. We identified 2,692 differentially expressed genes (DEGs) in miNs 
representing 1,251 up-regulated and 1,441 down-regulated genes in comparison to 
fibroblasts (log fold change ≥ 2; adjusted p-value < 0.01) (Figure 2A). A robust down-
regulation of fibroblast-specific genes (for instance, S100A4, VIM, FBN1 and, COL13A1) 
was accompanied an enrichment of pan-neuronal genes including MAP2, SCN1A, SNAP25, 
NRCAM, and NEFM (Figure 2A, 2B top two traces). Analysis of the top 10 gene ontology 
(GO) terms revealed that upregulated genes in miNs were primarily enriched with terms 
related to neuronal development and functionality (Figure 2C) while downregulated genes 
were associated with fibroblast functions (Figure 2C). Downregulated genes also included 
key cell-cycle components (data not shown), consistent with the previous finding that miR-
9/9*-124 expression in human fibroblasts caused rapid cell cycle exit without transitioning 
through a neural stem cell-like state (Yoo et al., 2011). Interestingly, neuronal subtype-
specific genes such as TH (dopaminergic neurons), GABBR2, GABR1, and GAD2 
(GABAergic neurons), CHAT (cholinergic neurons), or DARPP-32 (striatal medium spiny 
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neurons), were not significantly enriched in miNs (Figure 2B, bottom two traces as 
examples). Overall, our transcriptome analyses show that miR-9/9*-124 induce a neuronal 
state characterized by the loss of fibroblast identity and the presence of a pan-neuronal gene 
expression program without commitment to a particular subtype.
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Fig. 2. Gene Expression Profiling Reveals Pan-Neuronal Identity Induced 
by miRNAs Alone. 
(A) Genome wide expression analysis of miNs and starting fibroblasts by RNA-seq at day 
30 of reprogramming. Plot shows the relationship between average gene expression 
(logCPM) and log fold-change of miNs compared to fibroblasts. A selection of pan-
neuronal and fibroblast-specific genes are highlighted in black text. Blue = fold change < -2 
log2 p < 0.01 (more abundant in fibroblasts), grey = fold change > -2 log2 < 2 log2 p > 0.01, 
and red = fold change > 2 log2 p < 0.01 (more abundant in miNs). FDR < 0.01. 
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(B) Representative genome browser snapshots demonstrating increased expression for a 
pan-neuronal gene (NEFM), loss of fibroblast marker gene expression (S100A4), and 
absence of neuronal subtype marker gene expression (MNX1, motor neuron marker; 
DARPP-32, medium spiny neuron marker). 
(C) Gene ontology (GO) terms associated with genes upregulated in miNs (red) and GO 
terms associated with genes downregulated in miNs (blue). Right, examples of genes that 
fall within top GO categories listed. 
(D) Volcano plot representing chromatin modifier genes differentially expressed between 
fibroblasts and miNs. Blue dot, abs(logFC) > 2 and p < 0.01, red dot, abs(logFC) > 1 and p 
< 0.01, grey dot, no significant difference. See also Figure S2. 
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2.1.4 Transcriptional Changes in Epigenetic Machinery 
Epigenetic modifications can markedly affect gene expression and developmental 
programs (Cantone and Fisher, 2013). Our gene expression studies showed that when 
compared to fibroblasts, miNs had markedly altered expression of genes involved in DNA 
methylation, histone modifications, chromatin remodeling and chromatin compaction 
(Figures 2D and S2). For instance, the TET family of proteins, key mediators of DNA-
demethylation (Wu and Zhang, 2011) were upregulated along with the brain-enriched de 
novo DNA-methyltransferase DNTM3A (Lister et al., 2013), while DNMT3B (Okano et al., 
1999) mRNA levels were reduced in miNs compared to fibroblasts (Figures 2D and S2). 
Transcripts encoding histones and histone variants were altered (Figure S2) suggesting that 
changes in histone composition may accompany neuronal conversion of human fibroblasts. 
Genes encoding chromatin remodelers important for neurogenesis like CHD5, CHD7 and 
components of the BAF chromatin remodeling complex were expressed at higher levels in 
miNs than in fibroblasts (Egan et al., 2013; Feng et al., 2013; Lessard et al., 2007) (Figures 
2D and S2). Additionally, the main DNA topoisomerase 2 family member expressed in 
miNs is TOP2B, which replaces the non-neuronal TOP2A, a switch that has been observed 
during normal neuronal differentiation (Tiwari et al., 2012) (Figures 2D and S2). In sum, 
dynamic changes and switches within diverse epigenetic modifiers coincide with neuronal 
differentiation and appear to be recapitulated in direct neuronal conversion of fibroblasts by 
miR-9/9*-124.  
2.1.5 Dynamic Regulatory Events During Neuronal Reprogramming 
Because transcriptome profiling at day 30 only provided a snapshot of the functional 
output of neuronal reprogramming, we explored transcriptome dynamics by profiling 
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intermediary timepoints (days 3, 6, 10, and 20) by RNA-seq. The Dynamic Regulatory 
Events Miner (DREM) (Schulz et al., 2012) reports 13 paths of co-regulated, differentially 
expressed genes during the first 20 days of neuronal conversion (Figure 3A). Combining 
DREM with predicted TF-gene binding interactions (Ernst et al., 2010) revealed several 
potential TFs associated with major regulatory events (bifurcations in each path; Figure 
3A). Altogether, major regulatory events were observed before day 10, suggesting genetic 
networks were established within 10 days of miR-9/9*-124 expression. Thereafter, the 
directionality of gene expression stayed the same but transcript levels markedly changed. 
This transcriptional maturation over time may explain why the acquisition of functional 
neuronal characteristics requires 30 days of culture. GO analyses of each path revealed 
enrichment of neuronal terms in the most upregulated path, whereas down-regulated paths 
were enriched for cell cycle and extracellular matrix-related terms (Figure 3B), consistent 
with results for day 30 transcriptome profiling (Figure 2C). Other dynamically regulated 
paths included terms such as extracellular matrix, cell adhesion, and regulation of 
cytoskeleton, which are broadly reflective of the extensive morphological changes that 
occur during reprogramming. The transcriptome switch from a fibroblast to a neuronal 
program occurred as early as day 10 of miR-9/9*-124 expression, as fibroblast genes were 
repressed (e.g. MFAP5 and S100A4) and neuronal genes steadily increased in expression 
(e.g. SNAP25) while other genes associated with synaptic functionality appeared at day 20 
(e.g. HOOK1) (Figure 3C). 
Finally, there were no significant changes in ASCL1 or SOX2 (Figure S3F), TFs that 
have been used to reprogram somatic cells into neurons (Niu et al., 2013; Pang et al., 2011), 
suggesting miR-9/9*-124-induced neuronal conversion activates a neuronal program 
through mechanisms distinct from those previously reported. 
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Fig. 3. Time Series Transcriptome Analysis Reveals Early Dynamic Gene 
Expression Changes Followed by a Stable Transcriptome Switch 
 (A) Dynamic Regulatory Event Miner (DREM) analysis reveals multiple paths of co-
regulated genes emerge over time (days). Genes shown in each rectangle represent 
predicted transcription factors that may underlie the transcriptome changes detected. 
(B) GO terms enriched in each path (top) and heat maps of genes within the extracellular 
matrix and regulation of synaptic transmission terms (bottom). Z-score normalized RPKM. 
(C) Representative genome browser snapshots demonstrating the time-dependent loss of 
fibroblast gene expression (top), emergence of pan-neuronal marker gene expression, and 
synaptic component expression (bottom).  
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2.1.6 DNA Methylation Profiling of miNs 
After observing numerous changes in DNA methylation machinery we assessed 
genome-wide DNA methylation at an early (day 10), intermediate (day 20), and late stage 
(day 30) of neuronal reprogramming by combining methylated DNA immunoprecipitation 
sequencing (MeDIP-seq) and methylation sensitive restriction enzyme sequencing (MRE-
seq; Figure 4A) (Zhang et al., 2013). No significant changes in DNA methylation were 
detected at day 10 between cells that were exposed to miRNAs and non-treated control 
(Ctrl) cells. In contrast, we identified 1,540 differentially methylated regions (DMRs) at day 
20 (miN day 20 vs. Ctrl day 20) that overlap with DMRs at day 30 (miN day 30 vs. Ctrl day 
30; Figures 4B and 4C). The difference in DNA methylation at day 30 between treated and 
control cells was more dramatic than changes observed at day 20 with most DNA regions 
undergoing demethylation. Gene ontology (GO) analysis of Mouse Genome Informatics 
(MGI) expression using the GREAT (McLean et al., 2010) tool to characterize the top 
overlapping DMRs in miNs enriched only for neuronal tissue developmental processes 
(Figure 4D). Interestingly, these differentially methylated regions undergo changes at TS15 
in mouse development (equivalent to mouse E9/10), which is when miR-9 expression is first 
detected in developing mouse telencephalon (Shibata et al., 2008). Two examples of top 
DMRs within genes important for neuronal development and function are shown in Figure 
4E (Gehrke et al., 2010; Vadhvani et al., 2013). Nearly 64% of DMRs were located in 
introns and 28% of DMRs are in intergenic regions (Figure 4F). Comparison of data from 
day 30 demethylated and methylated DMRs and RNA-seq revealed 882 differentially 
expressed genes in total. GO analysis of top demethylated DMRs associated with 
upregulated genes (> 2.5 logFC) was enriched for neuronal terms. In contrast, top 
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methylated DMRs associated with down-regulated genes (< 2.5 logFC) did not match GO 
terms involved in neural development (Figure 4G; data not shown). Furthermore, since 
miR-9/9*-124 expression quickly induces cell cycle exit, these changes in DNA 
methylation must necessarily occur via active processes, such as those catalyzed by TET 
and TDG enzymes (Kohli and Zhang, 2013), rather than via failure to remethylate DNA 
after DNA replication. We should note that due to the need to isolate sufficient DNA, 
profiling of DNA methylation was performed using human neonatal fibroblasts, which grow 
faster and senesce much later than the human adult fibroblasts used throughout this 
manuscript, and could differ in some ways from results generated using adult cells. 
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Fig. 4. MiR-9/9*-124 Alter DNA Methylation at Neuronal Loci 
(A) Schematic of sample collection during miR-9/9*-124-mediated neuronal 
reprogramming for DNA methylation studies. Human fibroblasts were transduced with 
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virus expressing miR-9/9*-124 or a non-specific (NS) control (Ctrl) virus at day 0. Samples 
were collected at day 10, day 20, and day 30. 
(B) Biclustering analysis of DMRs. Heatmaps based on MeDIP-seq RPKM (left) and MRE-
seq RPKM (right) showing overlapping DMRs at days 20 and day 30.  
(C) Quantification of DMRs at multiple q-value cutoffs (q < 5e-2 in red; q < 5e-3 in yellow; 
q < 5e-4 in purple) across all time points: miN 10 (miN day 10 vs. Ctrl day 10), miN 20 
(miN day 20 vs. Ctrl day 20), and miN 30 (miN day 30 vs. Ctrl day 30).  
(D) Tissue development enrichment of top overlapping DMRs at day 20 and day 30 show 
neuronal tissue terms at TS15 (~E9/10 in mouse development).  
(E) WashU Epigenome Browser screenshots of two DMRs: FBXO31 (left) and 
MIRLET7BHG (right) loci are shown with MeDIP-seq tracks (red; top), MRE-seq tracks 
(green; middle), and DMR positions (purple; bottom).  
(F) Genomic distribution of differentially methylated and demethylated regions.  
(G) Functional enrichment of top demethylated and upregulated (red; left) or methylated 
and downregulated (blue; right) DMRs overlapping at day 20 and day 30 compared with 
RNA-seq at day 30. 
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2.1.7 Chromatin Remodeling in miNs  
Extensive expression changes in diverse chromatin remodeling genes during 
neuronal reprogramming (Figures 2D and S2) suggest that miR-9/9*-124 may also alter 
chromatin accessibility. We therefore performed Assay for Transpose-Accessible 
Chromatin followed by high throughput sequencing (ATAC-seq) 10 and 20 days after 
initiating miR-9/9*-124 induced neuronal conversion. A high correlation between replicates 
confirmed the reproducibility of our analyses (Figure 5A). We obtained 154,406 total peaks 
across all samples and identified 59,200 differential peaks (Figure 5B). Of the total peaks 
detected, 20,712 became more accessible (opened) and 38,882 peaks became inaccessible 
(closed). Most differential peaks in miNs at day 10 overlapped with the peaks at day 20 and 
the signal intensity of peaks gradually increased or decreased during the conversion (Figure 
5C), suggesting gradual transition of chromatin accessibility during reprogramming (Figure 
5C). Interestingly, the ratio of open intragenic to distal intergenic regions increased during 
miR-9/9*-124-mediated conversion (Figure 5D). 
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Fig. 5. MiR-9/9*-124 Globally Changes Chromatin Accessibility 
(A) Two-dimensional correlation plot of samples. Pearson’s correlation coefficient: 0.90 for 
Ctrl D10; 0.83 for miNs D10 (D10); 0.90 for miNs D20 (D20).  
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(B) Pie chart showing the proportion of differential peaks and total peaks. Differential peaks 
were obtained by combining all significant peaks (Ctrl D10 vs miNs D10, miNs D10 vs 
miNs D20).  
(C) Heatmaps showing signal intensity in opened and closed chromatin peaks across all 
time points. All opened and closed chromatin regions were ranked according to maximum 
intensity across all samples.  
(D) The genomic distribution of opened and closed chromatin regions.  
(E) Comparison of GO terms for genes with opened chromatin regions at promoters in miNs 
at day 10 and 20. 
(F) Heatmaps showing gene expression levels for DEGs positively correlated with ATAC-
seq signal intensities in their promoter regions. Signal intensity is based on normalized 
counts per million (CPM) values. Z-score normalized logCPM. 
(G) Top GO terms associated with DEGs that correlate with ATAC-seq signal intensity in 
promoter regions. Top (red): opened and upregulated genes. Bottom (blue): closed and 
downregulated genes. 
(H) Heatmaps showing ATAC signal intensities in the opened and closed chromatin regions 
in response to miR-9/9*-124, which overlapped with closed/heterochromatin and enhancer 
regions of fibroblasts.  
 I) Integrated genomics viewer (IGV) screenshots showing two different examples of 
ATAC-seq and RNA-seq integration, with genes being transcribed from left to right. An 
example of ATAC-seq and RNA-seq peaks within a pan-neuronal gene: MAP2 (left) and an 
example of ATAC-seq peaks (shaded green) within a subtype-specific locus without gene 
expression changes: MNX1 (right). See also Figures S3 and S4. 
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2.1.8 Erasure of Fibroblast Epigenetic Identity and Gain of Neuronal 
Chromatin Architecture  
To gain insight into biological relevance of changes in chromatin accessibility after 
miR-9/9*-124 expression, we performed gene enrichment analysis on genes with 
differential ATAC signals around the transcription start site ± 2Kb (TSS). We identified 
4,915 genes with gradual increases and 1,763 genes with gradual decreases in ATAC 
signals during conversion. Top GO terms associated with genes with increased ATAC 
signals are enriched in neuronal terms (Figure 5E), while closed regions were not (Figure 
S3A). The number of genes in open regions associated with neuronal terms gradually 
increased from day 10 to 20 consistent with our transcriptional profiling and coinciding 
with bona fide neuronal commitment of miNs (Figure 5E). Consistent with this hypothesis, 
chromatin accessibility for fibroblast marker genes like S100A4, S100A10, VIM and 
COL13A1 gradually decreased between 10 and 20 days into neuronal conversion. 
Collectively, our ATAC-seq analyses demonstrate miR-9/9*-124-induced chromatin 
remodeling events are characterized by concurrent closing of fibroblast-related genomic loci 
and opening of neuronal gene loci.  
Next, we examined whether miR-9/9*-124-induced chromatin accessibility 
correlated with changes in mRNA levels. We compared DEGs (logFC > 2 or < -2 adjusted 
p-value < 0.01) to genes with altered chromatin accessibility around the TSS and identified 
501 upregulated and 184 down-regulated genes that coincide with open and close regions, 
respectively (Figure 5F). GO enrichment analysis revealed that upregulated genes from 
opened regions associated with neurogenic terms, while downregulated genes from closed 
regions were connected with terms important for fibroblast function (Figure 5G, see S3E for 
example tracks). This demonstrates the concordant regulation of transcription and 
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chromatin accessibility mediated by miR-9/9*-124. Interestingly, some opened genomic 
regions that displayed no changes in gene expression contained genes that are specifically 
expressed in various neuronal subtypes, including those enriched in: dopaminergic neuron 
markers (TH and SLC6A3), serotonergic neuron markers (FEV, LMX1B and SLC6A4), 
GABAergic neuron markers (SLC6A1, SLC32A1, GAD2), striatal medium spiny neuron 
marker (PPP1R1B), glutamatergic neuron markers (GLUL and SLC1A6), and cholinergic or 
motor neuron markers (MNX1, CHAT, and SLC5A7) (Figure S3G for example tracks). 
These results suggest that miR-9/9*-124 poise the chromatin to accept additional inputs 
from subtype-specifying determinants without activating subtype-specific programs. In all, 
the chromatin dynamics observed during miRNA mediated neuronal conversion are 
consistent with time-dependent suppression of fibroblast identity concurrent with the 
opening of neuronal loci and activation of pan-neuronal gene expression. 
2.1.9 MicroRNA-induced Chromatin Remodeling at Heterochromatin 
Regions in Fibroblasts 
To gain a more complete understanding of the epigenetic architecture within opened 
and closed chromatin sites, we examined the relationship of these regions to pre-existing 
histone marks present in fibroblasts. We hypothesized that regions that close during 
reprogramming would overlap with the active enhancer/euchromatin marks H3K27ac and 
H3K4me1 in fibroblasts. Conversely, regions that open during neuronal reprogramming 
may overlap with heterochromatic H3K9me3 and H3K27me3 signatures pre-existing in 
fibroblasts. 
We selected 70,661 regions commonly marked by H3K27ac and H3K4me1 
(enhancer/euchromatin) and 5,843 regions commonly marked by H3K9me3 and H3K27me3 
(heterochromatin/closed) in human fibroblasts based on the Roadmap Epigenome database 
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(Roadmap Epigenomics et al., 2015). Strikingly, we found that 1,128 ATAC signal peaks 
present in day 20 miNs that displayed increased accessibility during the neuronal 
conversion overlapped with regions of fibroblasts marked by H3K9me3/H3K27me3, 
heterochromatic marks in fibroblasts, whereas H3K27ac/H3K4me1 euchromatic regions in 
fibroblasts overlapped with 16,207 peaks that were closed in miNs (Figure 5H). GO 
enrichment analysis of genes associated with open chromatin regions in miNs that were 
marked by H3K9me3 or H3K27me3 in fibroblasts resulted in neuronal differentiation and 
function-related terms (Figure S3B). In contrast, regions with decreased chromatin 
accessibility in miNs were enriched with non-neuronal terms (Figure S3D). These results 
demonstrate the surprising potency of miR-9/9*-124 to open heterochromatin regions 
needed for neuronal fate and to close enhancer regions associated with fibroblast fate. Our 
results collectively demonstrate that microRNAs can change chromatin architecture to 
promote neuronal and repress fibroblast fates during the direct conversion of human 
fibroblasts to neurons.  
2.1.10 Chromatin Remodeling is Required for Direct Conversion 
To further determine if chromatin changes were necessary for generating miNs, we 
knocked down the expression of BRG1, a core component of BAF chromatin remodeling 
complex whose reduced function has been shown to collapse the overall chromatin 
architecture (Kadoch et al., 2017) (Figure S4A). After 20 days of neuronal conversion, loss 
of BRG1 markedly decreased the number of MAP2-positive cells when compared to a 
control shRNA (Figure S4B and C). ATAC-seq revealed regions which failed to open in 
response to miR-9/9*-124 in the absence of BRG1 (Figure S4D and E). These regions were 
associated with neuronal GO terms in contrast to the fibroblast-related GO terms associated 
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with regions that failed to close (Figure S4F). These data demonstrate the requirement of 
chromatin remodeling during miR-9/9*-124-mediated neuronal conversion.  
2.1.11 Instructing the miRNA-induced Neurogenic State to a Motor 
Neuron Fate 
The deposition and removal of nucleosomes along regulatory elements within DNA 
inhibits or enables the binding of TFs, simultaneously facilitating and reinforcing cell-type 
specific gene expression programs (Jiang and Pugh, 2009). In our previous analyses we 
noted chromatin regions in miNs with enhanced accessibility were proximal to MNX1 and 
choline acetyl transferase CHAT, two of the hallmark genes expressed by motor neurons 
(Fonnum, 1973; Tanabe et al., 1998) (Figure 5I). Neither MNX1 nor CHAT mRNA levels 
were elevated in day 30 miNs after miR-9/9*-124 directed neuronal conversion, but we 
hypothesized the open chromatin would facilitate expression of these genes in response to 
motor neuron-specific TFs. To test this hypothesis, we expressed a panel of TFs known to 
promote motor neuron identity (Figure S5A) in combination with ectopic miR-9/9*-124 
expression, and assayed for MAP2 and MNX1 expression by immunostaining (data not 
shown). While all combinations resulted in MAP2 positive cells, only ISL1 and LHX3 
robustly led to the generation of MNX1-positive cells. Co-expressing LHX3 and ISL1 with 
miR-9/9*-124 in adult human fibroblasts from 22-, 42-, 56- and 68-year-old donors resulted 
in MAP2, TUBB3 and NCAM-positive cells with complex neuronal morphologies (Figures 
6A and 6B). Approximately 80% of cells positive for DAPI staining were positive for 
TUBB3, MAP2 and NCAM expression (Figure 6C). The majority of converted cells 
displayed nuclear staining of MNX1 (~85% of TUBB3 positive cells in each line, Figures 
6D and 6E). Similarly, cytoplasmic CHAT protein and SMI-32 (a neurofilament protein 
found in motor neurons) were detected in ~80% of TUBB3 positive cells within each age 
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group (Figure 6D and 6E).  
Interestingly, ISL1 and LHX3 alone were not sufficient to induce neuronal conversion when 
co-expressed with a non-specific miRNA (miR-NS) (Figure S5B), supporting the notion that 
miR-9/9*-124 is necessary for the subtype-specifying activities of ISL1 and LHX3. We also 
found the motor neuron conversion induced by miR-9/9*-124 with ISL1 and LHX3 to be 
stable, displaying neuronal morphologies, cell cycle exit, and motor neuron marker 
expression for 30 days after Dox removal (Figure 6F). 
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Fig. 6. MiRNA-Induced Neuronal Competence Enables Motor Neuron 
Transcription Factors, ISL1 and LHX3, to Determine Motor Neuron 
Identity. 
31 
 
(A) Schematic of neuronal induction paradigm using miR-9/9*-124 plus ISL1 and LHX3. 
(B) Representative immunohistochemistry for pan-neuronal markers in neurons generated 
from fibroblasts through 35 days of miR-9/9*-124, ISL1, and LHX3 co-expression. 
Fibroblasts were isolated from a 22-year-old female donor. Scale bars = 20m. 
(C) Quantification of 4 independent primary human fibroblast samples from male and 
female donors stained with TUBB3, MAP2 and NCAM. Percentages represent total number 
of positive cells over all cells (DAPI) and are represented as mean ± SEM. Cells (N) 
analyzed: 22 yr old N=TUBB3 325, MAP2 219, NCAM 275; 42 yr old N=TUBB3 304, 
MAP2 236, NCAM 129; 56 yr old N=TUBB3 275, MAP2 279, NCAM 213; 68 yr old 
N=TUBB3 282, MAP2 234, NCAM 190.  
(D) Expression and correct localization of motor neuron markers in neurons converted by 
miR-9/9*-124 and ISL1/LHX3 as demonstrated by immunohistochemistry. MNX1, (top), 
CHAT (middle) and SMI-32 (bottom). Scale bars = 20m. 
(E) Quantification of (D) represents the total percentage of MNX1, CHAT and SMI-32-
positive cells over TUBB3-positive cells. Data are represented as mean ± SEM. Cells 
analyzed: 22 yr old N=MNX1 256, CHAT 256, SMI-32 113; 42 yr old N= MNX1 151, 
CHAT 151, SMI-32 283; 56 yr old N= MNX1 207, CHAT 207, SMI-32 174; 68 yr old N= 
MNX1 151, CHAT 151, SMI-32 96. 
(F) After 30 days of neuronal conversion by ectopic miR-9/9*-124 expression, Dox was 
removed and cells were cultured for an additional 30 days. Immunocytochemistry showing 
motor neurons produced by miR-9/9*-124 plus ISL1 and LHX3 (Moto-miNs) remain Ki-67 
negative (2nd panel), retain expression and localization of the neuronal proteins TUBB3, 
NEUN, and MAP2 (2nd and 3rd panel), and express the motor neuron proteins MNX1 and 
CHAT (4th and 5th panel). Scale bars = 20m. 
See also Figure S5. 
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2.1.12 Electrophysiological properties of Moto-miNs 
Motor neurons produced from fibroblasts by co-expression of miR-9/9*-124, ISL1 
and LHX3 (Moto-miNs) demonstrated robust inward and outward currents in response to 
depolarizing steps (Figure 7A) and displayed AP trains through the injection of step-wise 
depolarizations (Figures 7B and S5C). The visualization of single traces recorded at 
individual current steps revealed the characteristic hyperpolarization following each action 
AP seen in mature neurons (Figure 7C). To assess the percentage of functionally mature 
Moto-miNs, we patched 45 randomly chosen Moto-miNs from 22-year-old and 68-year-old 
donors. All Moto-miNs fired APs in which most cells fired multiple APs (80% n = 20 and 
74% n = 25) while single APs were observed in ~20-25% of the patched cells (Figure 7D). 
Gap-free recordings in current clamp mode revealed cells capable of firing spontaneous APs 
(Figure 7E), demonstrating the excitability of the converted Moto-miNs. Similar I-V curve 
relationships were observed between donors and firing patterns (Figure 7F). Peak inward 
currents were substantially higher than those observed in miNs (Figure S6A). Lastly, resting 
membrane potentials in all Moto-miNs tested were hyperpolarized (Figure 7G; 22 yr old, -
67.2 mV ± 3.3 mV; 68 yr old, -72.8 mV ± 2.0 mV, S.E.M.). Coupled with the increased 
proportion of cells that fire multiple APs, these data suggest that the addition of ISL1 and 
LHX3 to miR-9/9*-124 produced more mature neurons than exposure to miR-9/9*-124 
alone.  
The ability of motor neurons to control voluntary muscle movement stems from 
their ability to form neuromuscular junctions (NMJs), unique synapses formed between 
motor neurons and muscle cells. The formation of NMJs was visualized through the co-
localization of EGFP-labeled Moto-miNs, Alexa-fluor-594 Bungarotoxin (BTX, a toxin that 
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binds to the nicotinic acetylcholine receptor (AChR) of NMJs), and myosin heavy chain. 
BTX puncta were not observed in the absence of Moto-miNs (Figure 7H, left inset). In 
contrast, Moto-miNs were able to induce characteristic BTX-clustering in close apposition 
with EGFP labeled neurons and myotubes (Figure 7H) indicating the formation of putative 
NMJs. 
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Fig. 7. Functional Properties and Gene Expression Profile of Moto-miNs 
(A) Representative traces of inward sodium and outward potassium whole-cell currents. 
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(B) Repetitive AP waveforms in response to 500 ms current injections recorded from Moto-
miNs in monoculture. 
(C) Representative waveforms of APs with increasing current injections. 
(D) Summary of firing patterns observed in Moto-miNs converted from both old and young 
donors. 68 yr old 80% multiple (N=20), 22 yr old 74% multiple (N=25).  
(E) Spontaneous AP generation observed in a small percentage of Moto-miNs (3/20). 
(F) Combined plot of the current (I) - voltage (V) relationship for all Moto-miNs recorded. 
Data are represented as mean ± SEM. 
(G) Moto-miNs converted from both young and old donors are hyperpolarized, 
demonstrating mean resting membrane potentials of -67.2mV and -72.8mV, respectively. 
Data are represented as mean ± SEM. 
(H) Staining of Moto-miNs cultured with differentiated human myotubes. Moto-miNs were 
labeled with synapsin-EGFP via viral transduction and then plated onto human myotubes. 
Myotube only cultures did not have -Bungarotoxin-594 (red) puncta (top left inset). Scale 
bar = 20m. 
(I) Scatterplot comparing the mean gene expression between starting fibroblasts from a 22-
year-old donor (y-axis) and miNs generated from the same individual (x-axis). Plot 
highlights a selection of pan-neuronal and fibroblast-specific genes in green text. Blue = 
log2FC < -2.5 and p < 0.05, (more abundant in fibroblasts) grey = log2FC > -2.5 and < 2.5 p 
> 0.05 (no significant difference), and red = log2FC > 2.5 and p < 0.05 (more abundant in 
miNs).  
(J) Scatterplot comparing the mean gene expression between miNs from a 22-year-old 
donor (y-axis) and Moto-miNs generated from the same individual (x-axis). Plot highlights 
a selection of pan-neuronal and motor neuron-specific genes in green text. Blue = log2FC < 
-2.5 and p < 0.05, (more abundant in miNs) grey = log2FC > -2.5 and < 2.5 p > 0.05 (no 
significant difference), and red = log2FC > 2.5 and p < 0.05 (more abundant in Moto-miNs).  
(K) qRT-PCR validation of fibroblast and motor neuron-specific genes. Moto-miNs were 
analyzed by qRT-PCR 35 days post-transduction. Human spinal cord RNA served as a 
positive control (normalized to 42 yr fibroblasts, ct method). Data are represented as 
mean ± SEM. 
(L) Moto-miNs express the motor neuron specific miRNA, miR-218. RNA was isolated 
from fibroblasts and Moto-miNs 35 days post-transduction and analyzed by qRT-PCR. Data 
are represented as mean ± SEM. 
(M) Moto-miNs retain HOX gene expression pattern of donor fibroblasts as demonstrated 
by qRT-PCR. ct method. Data represent ct values for each biological replicate (3 
separate Moto-miN conversions). See also Figure S6 and S7. 
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2.1.13 Transcriptional Profiling of Moto-miNs 
To fully characterize the acquisition of a motor neuron fate and assess the 
contribution of ISL1 and LHX3, we profiled the transcriptome of 22-yr-old starting 
fibroblasts, miNs and Moto-miNs by microarray. We again observed the loss of fibroblast 
gene expression (for example, S100A4, VIM and COL13A1), and the gain of a pan-neuronal 
identity (for example, MAP2, NEFL, SNAP25 and SCN1A) 35 days after the expression of 
miR-9/9*-124 (Figure 7I). Expression of motor neuron-specific genes was not significantly 
different between starting fibroblasts and miNs. While the addition of ISL1 and LHX3 to 
miR-9/9*-124 did not significantly change the expression of pan-neuronal genes when 
compared to miNs (Figure 7J), ISL1 and LHX3 selectively activated key motor neuron 
genes including MNX1, CHAT, VACHT, LMO1 and LMO4 (Figure 7J). We further validated 
the loss of fibroblast identity and gain of motor-neuron identity in Moto-miNs derived from 
42-, 56- and 68-year-old donors by qRT-PCR using RNA from human spinal cord as a 
positive control (Figure 7K). In addition, we observed dramatic upregulation of miR-218, a 
recently identified motor neuron-specific miRNA (Amin et al., 2015; Thiebes et al., 2015) 
in Moto-miNs (Figure 7L). 
Next, we used the cell type-specific enrichment analysis tool (CSEA) (Xu et al., 
2014) to test whether the gene expression profile within each population of miNs and Moto-
miNs would be associated with distinct subtypes of in vivo neurons. When queried with a 
gene list, CSEA identifies neuronal subtypes that show significant enrichment in genes from 
the input list through curated transcriptomic data. Our CSEA analysis of the 100 most 
enriched genes within Moto-miNs identified two subtypes, brainstem motor neurons and 
spinal motor neurons, to be significantly associated. No subtype specificity was assigned to 
37 
 
the miN transcriptome (Figure S6B). This unbiased bioinformatics approach further 
supports the motor neuron identity of converted Moto-miNs.  
Lastly, HOX gene expression patterns were compared by qRT-PCR between starting 
fibroblasts and Moto-miNs. Interestingly, we observed a high correlation (R2 = 0.88) 
between the expression levels of HOX genes before and after conversion within each of the 
defined spinal cord regions tested, indicating Moto-miNs retain the positional identity that 
existed in original fibroblasts (Figure 7M, S6C).  
2.1.14 Transcriptional Activation of ISL1 and LHX3 Genomic Targets 
An alternative approach for generating motor neurons is forced expression of 
NGN2, ISL1, and LHX3 in human embryonic stem cells (ESCs) (Mazzoni et al., 2013). We 
compared the genomic targets of ISL1 and LHX3 identified by Mazzoni et al. through 
ChIP-seq to genes whose expression increases in Moto-miNs compared to miNs. 
Surprisingly, we identified a large cohort of overlapping genes (323) that include numerous 
hallmark motor neuron markers (Figure S7A), suggesting that ISL1 and LHX3 activate 
expression of a core gene regulatory network that specifies the miR-9/9*-124-mediated 
neuronal conversion towards motor neurons. 
2.1.15 Comparison of Moto-miNs to Endogenous Spinal Cord Motor 
Neurons 
The inability to obtain a pure population of spinal cord motor neurons from human 
adults prevents direct transcriptional comparisons between Moto-miNs and their human in 
vivo counterparts. Therefore, we directly compared Moto-miNs to fully differentiated in 
vivo mouse spinal cord motor neurons. To interrogate the gene expression of motor neurons 
within the large heterogeneity of cell-types present in the spinal cord, we performed 
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Translating Ribosomal Affinity Purification (TRAP) followed by RNA-seq (Figure S7B). 
The use of two mouse lines expressing EGFP tagged ribosomes (one line under the pan-
neuronal SNAP25 promoter, and the other through the CHAT promoter), enabled the 
enrichment and subsequent sequencing of actively transcribed mRNA in all neurons and 
motor neurons within the spinal cord. We also profiled the transcriptome of the entire spinal 
cord as an additional ‘pre-IP’ control. Comparisons between CHAT pre-IP controls and 
CHAT-TRAP transcripts confirmed significant enrichment of motor neuron markers 
(Figure S7C, left) by the TRAP procedure. To further separate motor neuron enriched genes 
from common neuronal genes we first normalized CHAT-TRAP and SNAP-25 datasets to 
their pre-IP controls, then directly compared the normalized gene expression values. This 
analysis revealed the co-expression of pan-neuronal genes such as MAP2, NRCAM, SCN1A 
and TUBB3 and highly enriched for motor neurons transcripts such as SLC18A3 (VACHT), 
CHAT and MNX1 (Figure S7C, right). This dataset also serves as a resource for genes 
enriched in spinal cord neurons over all SNAP25 expressing neurons within the spinal cord. 
To that end, we compared differentially expressed mouse spinal cord motor neuron genes to 
genes enriched in Moto-miNs over miNs. We observed a significantly larger overlap 
between Moto-miNs and mouse motor neurons than expected by chance (Fisher’s exact test 
p = 3.522e-06), indicating that Moto-miNs and endogenous mouse motor neurons utilize 
similar genetic networks. This includes expression of canonical motor neuron markers such 
as, SLIT2 and SLIT3, host genes for the motor neuron specific miRNA, miR-218 (Amin et 
al., 2015) (Figure S7D). Altogether, our in-depth analyses of Moto-miNs at cellular, 
functional, and transcriptomic levels confirm that co-expression of miR-9/9*-124 and 
ISL1/LHX3 can directly convert adult fibroblasts into spinal cord motor neurons. 
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2.4 Supplemental Figures 
 
Fig. S1. MiRNA-Mediated Conversion into Neuronal Fate is Stable. 
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(A) Detailed schematic of miR-9/9*-124 direct conversion protocol. 
(B) Combined plot of the current (I) - voltage (V) relationship for all neurons recorded. 
(C) Tabulated values of resting membrane potentials in miNs. 
(D) Gap-free recording of resting membrane potential in a miN. 
(E) Tabulated values of capacitance values in miNs. 
(F) MiR-9/9*-124 was ectopically expressed under a doxycycline (DOX) inducible 
promoter in 22 year old human fibroblasts for 9 days then DOX was removed from the 
media at 3 day intervals. Cells were cultured until reprogramming day 30. Neuronal fate 
was assayed by immunostaining for the pan-neuronal marker MAP2 and the fibroblast 
identity was determined by FSP1 expression. Scale bar = 20µm. All data are represented 
as mean ± SEM. 
(G) MiR-9/9*-124 was ectopically expressed under a DOX-inducible promoter in 22 year 
old human fibroblasts for 30 days then DOX was removed from the media and cells were 
cultured for an additional 30 days. Stable adoption of the neuronal fate was assayed by 
immunostaining for the pan-neuronal markers MAP2, NEUN, TUBB3 and NCAM. To 
assay if cells remained post-mitotic cells were stained with the proliferative marker ki-67. 
Scale bar = 20µm. All data are represented as mean ± SEM. 
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Fig. S2. Expression Changes in Epigenetic Modifiers During 
Reprogramming. 
Heatmaps show expression changes observed between miNs and fibroblasts within a 
subset of proteins that influence chromatin state through various modes. 
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Fig. S3. Pre-existing Heterochromatic Neuronal Loci Open in Response to 
miR-9/9*-124 Expression. 
44 
 
(A) Top GO terms associated with promoter regions that close during reprogramming 
from fibroblasts to miNs. 
(B) Closed regions in fibroblasts marked by H3K9me3 that open during neuronal 
reprogramming are enriched for neuronal GO terms. 
(C) Closed regions in fibroblasts marked by H3K27me3 that open during reprogramming 
are also enriched for neuronal GO terms. 
(D) Pre-existing distal H3K27ac and H3K4me1 marks within fibroblasts that close 
during neuronal reprogramming show GO terms related to general biological processes. 
(E) Genome browser snapshots demonstrating closing and loss of fibroblast gene 
expression (ECM1, MFAP5, and VIM). 
(F) Genome browser snapshots demonstrating neither opening or activation of progenitor 
genes (SOX2, OLIG2 and ASCL1). 
(G) Genome browser snapshots demonstrating neuronal subtype gene loci that open, but 
do not show gene expression changes (GAD2 and GABRA2, GABAergic markers; TH, 
dopaminergic neuron marker). Shaded green: location of differential ATAC peaks 
detected. 
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Fig. S4. Loss of BRG1 Prevents Neuronal Fate Acquisition 
(A) BRG1 expression in human fibroblasts expressing shCTRL or shBRG1 
(B) Adult human fibroblasts ectopically expressing miR-9/9*-124 and shBRG1 or 
shCTRL for 20 days, immunostained for the pan-neuronal marker MAP2 and fibroblast 
marker FSP1. Scale bars = 20µm. 
(C) Quantification of (B) MAP2 and FSP1 positive cells over total number of cells 
(DAPI). Scoring for MAP2-positive cells, only cells with processes at least three times 
the length of the soma were counted. Data are represented as mean ± SEM. shBRG1 n = 
155 cells, shCTRL, n = 173 cells. 
(D) Heatmaps showing ATAC signal intensity in open and close chromatin peaks in 
shBRG1 and shCTRL. All open and closed chromatin regions were ranked according to 
maximum intensity across all samples. 
(E) The genomic distribution of ATAC signals in cells expressing miR-9/9*-124 and 
shCTRL or shBRG1. 
(F) GO terms showing biological function of closed (lost in shBRG1, red) and open 
(retained in shBRG1, blue) regions. 
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Fig. S5. Identification of Transcription Factors for Defining Motor Neuron 
Specific Conversion 
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(A) Candidate motor neuron transcription factors and combinations co-expressed with 
miR-9/9*-124 in human fibroblasts. 
(B) Immunocytochemistry of adult human fibroblasts overexpressing a non-specific 
miRNA (miR-NS) and ISL1/LHX3 (left) or miR-9/9*-124 and ISL1/LHX3 (right) for 35 
days. Images demonstrate the necessity of miR-9/9*-124 for opening the neurogenic 
potential of human fibroblasts. Scale bar = 20µm. 
(C) Additional representative inward/outward whole-cell currents and repetitive AP 
waveforms generated from whole cell patch clamp recordings of Moto-miNs. Images 
show the patch clamped cells. 
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Fig. S6. Addition of ISL1/LHX3 to miR-9/9*-124 Increases Functional 
Maturity and Generates Motor Neuron Transcriptional Network. 
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(A) Peak inward current measured during voltage clamp mode of miNs and Moto-miNs 
reveals increased peak inward current in Moto-miNs (-3,189 pA ± 214 pA) compared to 
miNs (-919 pA ±113 pA). Data are represented as mean ± SEM. 
(B) Cell Type-specific Enrichment Analysis (CSEA) tool reveals the top 100 most 
significantly expressed genes in miNs do not enrich for defined neuronal subtypes (left), 
while the top 100 most significantly expressed genes in Moto-miNs are enriched in 
cholinergic motor neurons in the brain stem and spinal cord. 
(C) HOX gene expression analysis by qRT-PCR in 42-year-old female and 56-year-old 
male donor fibroblasts before and after conversion confirms that Moto-miNs retain donor 
fibroblast HOX gene expression patterns. Data represent CT values for each biological 
replicate (3 separate Moto-miN conversions). 
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Fig. S7. Direct Comparison of Moto-miN Transcriptome to in vivo Mouse 
Motor Neurons by Translating Ribosomal Affinity Purification (TRAP) 
Sequencing. 
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(A) Venn Diagram depicting the number of ISL1/LHX3 ChiP-seq peaks identified by 
Mazzoni et al. during ISL1/LHX3 directed ES to motor neuron differentiation (3,486) 
and genes enriched in Moto-miN transcriptome (775). Heatmap shows overlapping 
activated genes (323) include hallmark motor neuron markers. 
(B) Schematic of TRAP-Seq strategy used to identify transcripts in all neurons (SNAP-
25 genetic driver) and motor neurons (CHAT genetic driver) in mouse spinal cord. TRAP 
is a method to precipitate actively translated mRNA bound to ribosomes using an 
antibody to EGFP-L10A. 
(C) Pairwise comparisons between mean expression values in CHAT IP v. Pre-IP (left) 
and CHAT IP v. SNAP25 IP (right). Differentially expressed genes are shown in red 
(logFC > 1 and p < 0.05) and blue (logFC < -1 and p < 0.05). 
(D) Example mean expression values of overlapping genes between human (Moto-miNs 
versus miNs) and mouse (all spinal cord neurons SNAP25-TRAP) and motor neurons 
(ChAT-TRAP) datasets. 
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Supplemental Table 1 
Related to STAR Methods section.  Primer sequences used for qRT PCR analysis 
 
Primer Name Sequence (5'-3') 
S100A4 FWD GATGAGCAACTTGGACAGCAA 
S100A4 REV CTGGGCTGCTTATCTGGGAAG 
VIM FWD AGTCCACTGAGTACCGGAGAC 
VIM REV CATTTCACGCATCTGGCGTTC 
COL13A1 FWD GGAGACGGCTATTTTGGGACG 
COL13A1 REV TCCTTGAGTGGAGCTTCCATT 
ChAT FWD TCAATCATGTCCAGCGAGTC 
ChAT REV AACGAGGACGAGCGTTTG 
HB9 FWD CTCCTACTCGTACCCGCAG 
HB9 REV TTGAAGTCGGGCATCTTAGGC 
SLC18A3 FWD TTCGCCTCTACAGTCCTGTTC 
SLC18A3 REV GCTCCTCCGGGTACTTATCG 
HOXB4 FWD CGTGAGCACGGTAAACCCC 
HOXB4 REV CGAGCGGATCTTGGTGTTG 
HOXC6 FWD ACAGACCTCAATCGCTCAGGA 
HOXC6 REV AGGGGTAAATCTGGATACTGGC 
HOXA7 FWD CGTTCCGGGCTTATACAATGT 
HOXA7 REV CTCGTCCGTCTTGTCGCAG 
HOXB7 FWD TTCCCAGAACAAACTTCTTGTGC 
HOXB7 REV GCATGTTGAAGGAACTCGGCT 
HOXC8 FWD ACCGGCCTATTACGACTGC 
HOXC8 REV TGCTGGTAGCCTGAGTTGGA 
HOXD8 FWD GGAAGACAAACCTACAGTCGC 
HOXD8 REV TCCTGGTCAGATAGGGGTTAAAA 
HOXA9 FWD TACGTGGACTCGTTCCTGCT 
HOXA9 REV CGTCGCCTTGGACTGGAAG 
HOXC9 FWD ACTCGCTCATCTCTCACGACA 
HOXC9 REV GACGGAAAATCGCTACAGTCC 
HOXD9 FWD GGACTCGCTTATAGGCCATGA 
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HOXD9 REV GCAAAACTACACGAGGCGAA 
HOXC10 FWD ACATGCCCTCGCAATGTAACT 
HOXC10 REV GAGAGGTAGGACGGATAGGTG 
HOXC11 FWD ATGTTTAACTCGGTCAACCTGG 
HOXC11 REV GCATGTAGTAAGTGCAACTGGG 
HOXD11 FWD TCTCCGAGTCCTCGTGGGGA 
HOXD11 REV GCAAAACACCAGCGCCTTCTA 
HPRT FWD TCCTTGGTCAGGCAGTATAATCC 
HPRT REV GTCAAGGGCATATCCTACAACAAA 
  
 
2.5 Materials and Methods 
Primary Cell Cultures 
Primary fibroblasts utilized in this study: 1-year-old male (PCS-201-010, ATCC), 22-
year-old female (GM02171, NIGMS Human Genetic Cell Repository at the Coriell Institute for 
Medical Research), 42-year-old female (F09-238, Washington University in St. Louis School of 
Medicine iPSC core facility), 56-year-old male (AG04148, NIA Aging Cell Repository at the 
Coriell Institute for Medical Research), and 68-year-old female (ND34769, NINDS Cell Line 
Repository at the Coriell Institute for Medical Research).  Human skeletal myoblasts (HSMM) 
were obtained from a commercial source (Lonza, CC-2580). The sex of the human skeletal 
myoblasts was not provided; however, these cells were not used for neuronal conversion and 
therefore the sex of HSMM would not change the conclusions drawn from the current study. 
Mice 
Mouse lines Tg(Chat-EGFP/Rpl10a)DW167Htz (JAX: 030250) and Tg(Snap25-
EGFP/Rpl10a)JD362Jdd (JAX: 030273) were purchased from Jackson Laboratory. All the mice 
were housed under pathogen-free conditions in the East McDonnell animal housing facility of 
Washington University in St. Louis under a 12 hr light-dark cycle. 21-day-old pooled male and 
female mice were used in the TRAP-seq studies; see Method Details for TRAP procedure. All 
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the subjects were not involved in any previous procedures.  
Ethics statement:  
The Washington University Animal Studies Committee approved all procedures used for 
the mouse experiments described in the present study. Overall care of the animals was consistent 
with The Guide for the Care and Use of Laboratory Animals from the National Research Council 
and the USDA Animal Care Resource Guide. 
Cell Culture 
Adult and neonatal human fibroblasts were maintained in fibroblast media comprised of 
Dulbecco’s Modified Eagle Medium (Invitrogen) supplemented with 15% fetal bovine serum 
(Life Technologies), 0.01% β- mercaptoethanol (Life Technologies), 1% non-essential amino 
acids, 1% sodium pyruvate, 1% GlutaMAX, 1% 1M HEPES buffer solution, and 1% 
penicillin/streptomycin solution (all from Invitrogen). Cells were never passaged more than 15 
times. 
Plasmid construction and virus production 
Complementary cDNA was generated from adult human spinal cord (Clontech) from 
which individual motor neuron transcription factors (Figure S5A) were subcloned into the N174 
and N106 lentiviral vectors using standard techniques. Lentivirus was produced in Lenti-X 293T 
(293LE; Clontech, cat. no. 632180) cells. 293LE cells plated in 10cm dishes (6.5 x 10^6 cells per 
dish) via polyethylineimine (48 μL of 2 mg/mL, Polysciences) assisted transfection of 2nd 
generation packaging vectors (1.5 μg pMD2.G and 4.5 μg psPAX2), and 6 μg of lentiviral 
backbone plasmid (e.g. pT-BCL-9/9*-124) 16 hours after initial plating. Media was changed the 
next day. After 2 days, media was collected, filtered through a 0.45 μm polyethersulfone (PES) 
syringe filter and concentrated by centrifugation at 70,000xG for 2 hours at 4C. Virus collected 
55 
 
from a single 10 cm dish was resuspended in 1 mL of sterile PBS then aliquoted and stored at -
80C. Before each transduction, virus aliquots were spun at 5,000xG for 5 minutes at 4C to 
remove debris. Control vector expressing non-specific (NS) miRNA and BCL-XL was generated 
previously (Victor et al., 2014). Lentiviral BRG1 shRNA was generated by annealing then 
ligating the following sequences into the pLKO vector (Addgene, 8453), shBRG1 FWD 5’ 
CCGGGGTGCTCAACACGCACTATGTCTCGAGACATAGTGCGTGTTGAGCACCTTTTT
G 3’, shBRG1 REV 5’ 
AATTCAAAAAGGTGCTCAACACGCACTATGTCTCGAGACATAGTGCGTGTTGAGCAC
C 3’.  
Direct Neuronal Conversion 
To initiate direct conversion, 1.8x10^6 cells were seeded onto Costar 6-well cell culture 
plates (Corning; 300,000 cells/well). The following day, each plate was transduced with the 
following reprogramming cocktail: 750 uL of concentrated lentivirus containing the reverse 
tetracycline-controlled transactivator (rtTA; Addgene, 66810) and 500 μL of virus containing 
pT-BclXL-9/9*-124 or pT-BclXL-9/9*-124 plus 500 μl of each individual TF driven by the 
EF1 promoter in the presence of polybrene (8 μg/mL; Sigma-Aldrich) all diluted up to 18 mL 
(3 mL per well) then spinfected at 37C for 30 minutes at 1,000xG using a swinging bucket 
rotor. The following day media was changed to fresh fibroblast media (2 mL per well) 
supplemented with doxycycline (Dox; Sigma Aldrich, 1 μg/mL). After 2 days, fresh fibroblast 
media was changed and supplemented with Dox and antibiotics for respective vectors 
(Puromycin, 3 μg/mL; Blasticidin 5 μg/mL; Geneticin, 400 ug/mL; all from Invitrogen). Five 
days post-transduction cells were replated on to poly-ornithine/laminin/fibrobnectin (PLF) 
coated glass coverslips. Before PLF coating, glass coverslips were acid treated as previously 
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reported (Richner et al., 2015). To transfer cells, for each well of a 6 well plate, cells were first 
washed 2x with 1 mL sterile PBS. Then 320 μL of 0.25% Trypsin (Gibco) was added to each 
well then placed in an incubator. Cells were monitored every 2 minutes. As soon as cells began 
to detach (no more than 6 minutes), 1 ml of fibroblast media supplemented with 1 μg/mL Dox 
was added to each well. One by one, each well was gently triturated three times to remove 
remaining attached cells then transferred to a sterile 1.5 mL Eppendorf tube. Cells were then 
spun at 200xG for 5 minutes at 37C. The supernatant was aspirated and cells were gently 
resuspended in 300 μL fibroblast media supplemented with Dox. Cells were then drop-plated 
onto either 18 mm (150 μL per coverslip; placed in 12 well plate) or 12mm (60 μL per coverslip; 
placed in 24 well plate) coverslips. Cells were left to settle for 15 minutes in an incubator then 
each well was flooded with fibroblast media supplemented with 1 μg/mL Dox. The following 
day media was then changed to Neuronal Media (ScienCell, 1521) supplemented with Dox, 
valproic acid (1 mM; EMD Millipore) dibutyryl cAMP (200 μM; Sigma-Aldrich), BDNF, NT-3, 
CNTF, GDNF (all 10 ng/mL, Peprotech), and Retinoic Acid (1 uM; Sigma-Aldrich) and 
antibiotics for each vector. Dox was replenished every two days and half the media was changed 
every 4 days. Drug selection was stopped 14 days into conversion. A diagram of the 
reprogramming protocol is available in Figure S1.  
For time-course studies, the above reprogramming protocol was utilized with the 
following exception. In 3-day intervals starting on reprogramming day 9, a full media change 
excluding Dox was used to effectively remove Dox from the well at each timepoint. 
For DNA methylation profiling, 1.8x10^6 human neonatal fibroblasts were seeded onto 
10 cm plates (Corning). To achieve the cell number required for meDIP and MRE-seq human 
neonatal fibroblasts were utilized as adult fibroblasts were unable to expand to sufficient 
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quantities. The following day, each plate was transduced with 10 ml of un-concentrated 
lentivirus containing media with a doxycycline inducible miR-9/9*-124 vector (Victor et al., 
2014) and polybrene (8 μg/mL; Sigma-Aldrich). The following day media was changed to fresh 
fibroblast media (2 mL per well) supplemented with Dox. After 2 days, fresh fibroblast media 
was changed and supplemented with Dox and antibiotics for respective vectors (see Table 1). 
Seven days post-transduction, cells were first washed 2x with 3 mL sterile PBS. Then 1 ml of 
0.25% Trypsin (Gibco) was added to each plate then placed in a 37oC tissue culture incubator. 
Cells were monitored every 2 minutes and as soon as cells began to detach (no more than 6 
minutes), 4 ml of fibroblast media supplemented with 1 μg/mL Dox was added to each plate. 
Cells were transferred to Primaria modified 10 cm plates (Corning) and 5 ml fresh fibroblast 
media supplemented with 1 μg/mL Dox was added to a final volume of 10 ml. The following day 
media was changed to Neuronal Media (Sciencell) supplemented with Dox, valproic acid (1 mM; 
EMD Millipore) dibutyryl cAMP (200 μM; Sigma-Aldrich), BDNF, and NT-3 (all 10 ng/mL, 
Peprotech), Retinoic Acid (1 uM; Sigma-Aldrich), and 4% FBS. Dox was replenished every two 
days and half the media was changed every 4 days. 
Myotube Differentiation 
Human myotubes were generated by differentiating human myoblasts using defined 
culture conditions (Steinbeck et al., 2016). Briefly, human skeletal myoblasts were cultured 
according to manufacturers recommendations (HSMM; Lonza, CC-2580) then were plated on 
matrigel (0.1mg/mL) coated 12mm glass coverslips at a density of 80,000 cells/well. The 
following day HSMM’s were differentiated by switching media to skeletal muscle differentiation 
media comprised of a 1:1 mixture of DMEM F12 (Gibco) and Complete Neuronal Media + 2% 
Horse Serum (Gibco). Every 2 days 75% of the media was replaced with fresh differentiation 
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media. After 10-14 days of differentiation, Moto-miNs 14 days into conversion and labeled with 
synapsin-eGFP via lentiviral transduction were replated onto the established myotubes at a 1:1 
ratio (i.e. one 12mm Moto-miN coverslip was replated on top of a 12mm myotube coverslip). 
The following day media was changed to complete neuronal media and cells were cultures for 2 
weeks. Dox was replenished every two days and half the media was changed every 4 days. After 
two weeks cells were fixed with 4% paraformaldehyde and processed for immunocytochemistry 
and α-Bungarotoxin staining.  
Immunocytochemistry 
Cells were fixed using 4% formaldehyde for 18 minutes at room temperature (RT) then 
blocked and permeabilized for one hour at room temperature in PBS containing 0.3% Triton-
X100, 5% bovine serum albumin (Sigma-Aldrich), and 2% of either goat or donkey serum 
(Sigma-Aldrich). Primary antibodies were incubated overnight at 4C in blocking buffer. Cells 
were then washed 3x and incubated with secondary antibodies conjugated to either Alexa-488, -
594 or -647, for one hour at room temperature. α-Bungarotoxin was incubated with secondary 
antibodies at a concentration of 1:200. Images were obtained on a Leica SP-2 Confocal 
Microscope.  
Electrophysiology 
Whole-cell patch-clamp recordings were performed 35-40 days post-transduction. Data 
was acquired using pCLAMP 10 software with multiclamp 700B amplifier and Digidata 1550 
digitizer (Molecular Devices). Electrode pipettes were pulled from borosilicate glass (World 
Precision Instruments) and typically ranged between 5–8 MΩ resistance. Intrinsic neuronal 
properties were studied using the following solutions (in mM): Extracellular: 140 NaCl, 3 KCl, 
10 Glucose, 10 HEPES, 2 CaCl2and 1 MgCl2
 
(pH adjusted to 7.25 with NaOH). Intracellular: 
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130 K- Gluconate, 4 NaCl, 2 MgCl2, 1 EGTA, 10 HEPES, 2 Na-ATP, 0.3 Na-GTP, 5 Creatine 
phosphate (pH adjusted to 7.5 with KOH). Membrane potentials were typically kept at -65 mV. 
In voltage-clamp mode, currents were recorded with voltage steps ranging from -20 mV to +90 
mV. In current-clamp mode, action potentials were elicited by injection of step currents that 
modulated membrane potential from -10 mV to +35 mV. Data was collected in Clampex and 
initially analyzed in Clampfit (Molecular Devices). Further analysis was done in GraphPad 
Prism 7 (GraphPad Software). Liquid junction potential was calculated to be 15.0 mV and 
corrected in calculating resting membrane potential according to previously published methods 
(Barry, 1994).  
RNA-Sequencing 
Total RNA from day 30 miNs and starting human adult fibroblasts (22 yr old) were 
extracted by RNeasy plus micro kit (Qiagen). The RNA samples with > 9.5 of RIN based on a 
2100 Bioanalyzer were used for RNA-Seq library preparation. Library preparation and 
sequencing were performed by Genome Technology Access Center in Washington University 
School in St. Louis. Briefly mRNA was isolated by using SMARTer Ultra Low RNA Kit for 
Illumina sequencing (Clontech). All cDNA libraries, based on two biological replicates for each 
condition, were sequenced on Illumina Hi-Seq 2500 with single-end 50 bp read length.  
For RNA-seq time series data in Figure 3, total RNA was extracted from starting human adult 
fibroblasts (22 yr old) and day 3, 6, 10, and 20 miNs by RNeasy plus micro kit (Qiagen). The 
RNA samples with > 9.5 of RIN based on a 2100 Bioanalyzer were used for RNA-Seq library 
preparation. Total RNA was processed for library construction by Cofactor Genomics 
(http://cofactorgenomics.com, St. Louis, MO) according to the following procedure: Briefly, 
total RNA was reverse-transcribed using an Oligo(dT) primer, and limited cDNA amplification 
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was performed using the SMARTer® Ultra® Low Input RNA Kit for Sequencing – v4 (Takara 
Bio USA, Inc., Mountain View, CA). The resulting full-length cDNA was fragmented and 
tagged, followed by limited PCR enrichment to generate the final cDNA sequencing library 
(Nextera® XT DNA Library Prep, Illumina, San Diego, CA). Libraries were sequenced as 
single-end 75 base pair reads on an Illumina NextSeq500 following the manufacturer's 
instructions by Cofactor Genomics. 
DREM Analysis 
The Dynamic Regulatory Events Miner (DREM) and cDREM were used to integrate time 
series gene expression data with predicted TF-gene binding interactions (top 100 genes per 
PWM from Ernst et al., 2010 to identify patterns of temporal gene expression patterns and the 
associated regulators. The log fold change of 7310 DE genes (fold-change > 10; q-value < 0.1) 
was used to generate all paths in Figure 3. 
MicroArray 
Total RNA was extracted from miNs and Moto-miNs derived from 22 yr old donor 
fibroblasts alongside corresponding starting fibroblast controls using TRIzol (Thermo Fisher 
Scientific, Waltham, MA) according to the manufacturer’s instruction followed by extraction 
using chloroform and then ethanol precipitation. RNA quality was determined by the ratio of 
absorbance at 260 nm and 280 nm to be approximately 2.0. Samples for RNA microarray were 
then standardly prepped and labeled with Illumina TotalPrep kits (Thermo Fisher Scientific, 
Waltham, MA) for Agilent Human 4x44Kv1. Standard hybridization and imagine scanning 
procedure were performed according to the manufacturer's protocol at Genome Technology 
Access Center at Washington University School of Medicine, St. Louis.  
Methylated DNA immunoprecipitation sequencing 
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MeDIP-seq was performed as in Maunakea et al. (Maunakea et al., 2010). Five 
micrograms of genomic DNA was sonicated to a fragment size of ~100-400 bp using the 
Bioruptor sonicator (Diagenode). End-repair, addition of 3’-A bases and PE adapter ligation with 
2 g of sonicated DNA was performed according to the Illumina Genomic DNA Sample Prep 
Kit protocol. Adapter-ligated DNA fragments were size selected to 166-366 bp and purified by 
gel electrophoresis. DNA was heat denatured and then immunoprecipitated with 5-
methylcytidine antibody (Eurogentec; 1 g of antibody per 1 g of DNA) in 500 l of 
immunoprecipitation buffer (10 M sodium phosphate, pH 7.0, 140 mM sodium chloride and 
0.05% Triton X-100) overnight at 4 C. Antibody/DNA complexes were isolated by addition of 
1 l of rabbit anti-mouse IgG secondary antibody (2.4 mg ml-1, Jackson Immunoresearch) and 
100 l protein A/G agarose beads (Pierce Biotechnology) for 2 h at 4 C. Beads were washed 
nine times with immunoprecipitation buffer and then DNA was eluted in TE buffer with 0.25% 
SDS and 0.25 mg/mL of proteinase K for 2 h at 50 C. DNA was then purified with the Qiagen 
QIAquick kit and eluted in 30 l EB buffer. Ten microliters of DNA was used for a PCR-
enrichment reaction with PCR PE Primers 1.0 and 2.0. PCR products were size selected (220-
420 bp) and purified by gel electrophoresis. Methylated DNA enrichment was confirmed by PCR 
on known methylated (SNRPN and MAGEA1 promoters) and unmethylated (a CpG-less 
sequence on chromosome 15 and glyceraldehyde 3-phosphate dehydrogenase promoter) 
sequences. DNA libraries were checked for quality by Nanodrop (Thermo Scientific) and 
Agilent DNA Bioanalyzer (Agilent). Reads were aligned to hg19 using BWA and pre-processed 
using methylQA (an unpublished C program; available at http://methylqa.sourceforge.net/). 
Detailed library construction protocols for MRE-seq and MeDIP-seq are publically available at 
the NIH Roadmap Epigenomics project website 
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(http://www.roadmapepigenomics.org/protocols/type/experimental/). 
Me-sensitive restriction enzyme sequencing 
Methylation (Me)-sensitive enzyme sequencing (MRE-seq) was performed as in 
Maunakea et al. (Maunakea et al., 2010), with modifications as detailed below. Five parallel 
restriction enzyme digestions (HpaII, Bsh1236I, SsiI(AciI) and Hin6I (Fermentas), and 
HpyCH4IV (NEB)) were performed, each using 1 g of DNA per digest for each of the samples. 
Five units of enzyme were initially incubated with DNA for 3 h and then an additional five units 
of enzyme were added to the digestion for a total of 6 h of digestion time. DNA was purified by 
phenol/chloroform/isoamyl alcohol extraction, followed by chloroform extraction using phase 
lock gels. Digested DNA from the different reactions was combined and precipitated with one-
tenth volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes of ethanol. The purified DNA was 
size selected and purified (50-300 bp) by gel electrophoresis and Qiagen MinElute extraction. 
Library construction was performed as per the Illumina Genomic DNA Sample Prep Kit protocol 
with the following modifications. During the end-repair reaction, T4 DNA polymerase and T4 
PNK were excluded and 1 l of 1:5 diluted Klenow DNA polymerase was used. For the adapter 
ligation reaction, 1 l of 1:10 diluted PE adapter oligo mix was used. Ten microliters from the 30 
l of purified adapter ligated DNA was used for the PCR enrichment reaction with PCR PE 
Primers 1.0 and 2.0. PCR products were size selected and purified (170-420 bp) by gel 
electrophoresis and Qiagen QIAquick extraction. DNA libraries were checked for quality by 
Nanodrop (Thermo Scientific) and Agilent DNA Bioanalyzer (Agilent). Reads were aligned to 
hg19 using BWA and pre-processed using methylQA. MRE reads were normalized to account 
for differing enzyme efficiencies and methylation values were determined by counting reads with 
CpGs at fragment ends (Maunakea et al., 2010). 
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Genomic features 
DMRs from day 30 (miN day 30 vs. Ctrl day 30) were segregated into exons, introns, 
intergenic regions, 3’ UTRs, 5’ UTRs, non-coding regions, promoter-TSSs, and TTSs by using 
the annotatePeaks program provided by HOMER (Heinz et al., 2010). 
ATAC-sequencing  
ATAC-seq was performed as previously described (Buenrostro et al., 2013). Briefly, 
50,000 cells were collected for ATAC-seq library preparation at Ctrl day 10, miNs day 10, miNs 
day 20, shBRG1 day 20 and shCTRL day 20. Transposition reaction was carried out with 
Nextera Tn5 Transposase for 30 min at 37 °C. Library fragments were amplified for optimal 
amplification condition. Final libraries were purified using AMPure XP beads (Ampure) and 
sequenced with 50 bp paired-end reads on Illumina HiSeq 2500.  
Translating ribosome affinity purification 
Translating ribosome affinity purification (TRAP) (Heiman et al., 2014) was performed 
on spinal cord dissections pooled from 3-4 mice 21 days post birth that were positive for the 
eGFP-L10A fusion ribosomal marker protein under either the Chat promoter (Tg(Chat-
EGFP/Rpl10a)DW167Htz) or the Snap25 promoter (Tg(Snap25-EGFP/Rpl10a)JD362Jdd). 
TRAP samples underwent immunopurification for four hours at 4C. Both TRAP and pre-
immunopurification control RNA samples were extracted through TRIzol purification, DNase 
treatment, and Qiagen RNeasy Mini columns (74104). Quality and quantity of RNA was 
assessed using a Bioanalyzer 2100 RNA Pico Chip. Sequencing libraries were amplified using 
Nugen Amplification Kit Ovation® RNA Seq System V2 (7102). Genome Technology Access 
Center at Washington University in St. Louis performed adapter ligation and sequencing of the 
libraries on the Illumina Hiseq2500. Three replicates of this procedure were analyzed.  
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Immunoblot analysis  
Human fibroblasts (ATCC) expressing shBRG1 or shCtrl were lysed 7 days post-
transduction in RIPA buffer (Thermo Scientific) supplemented with protease inhibitors (Roche). 
The concentrations of whole cell lysates were measured using the Pierce BCA protein assay kit 
(Thermo Scientific). Equal amounts of whole cell lysates were resolved by SDS-PAGE and 
transferred to a nitrocellulose membrane (GE Healthcare Life Sciences) using a transfer 
apparatus according to the manufacturer’s protocols (Bio-rad). After incubation with 5% BSA in 
TBS containing 0.1% Tween-20 (TBST) for 30 min, the membrane was incubated with primary 
antibodies at 4°C overnight. Following incubation, membranes were incubated with a 
horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibody for 1 hr. Blots were 
developed with the ECL system (Thermo Scientific) according to the manufacturer’s protocols.  
Quantitative PCR 
Total RNA was extracted using TRIzol (Invitrogen, USA) according to the 
manufacturer's instruction. Reverse-transcribed complementary DNA (cDNA) was synthesized 
from 500ng of RNA with SuperScript III First-Strand Synthesis SuperMix (Invitrogen, USA) or 
from 10 ng of RNA for microRNA expression analyses using specific stem-loop primer probes 
from TaqMan MicroRNA Assays (Invitrogen, USA). Subsequently, the cDNA was analyzed on 
a StepOnePlus Real-Time PCR System (AB Applied Biosystems, Germany). The following 
primers were utilized: 
miRNA qRT-PCR primers 
hsa-miR-218 (Thermo Fisher Cat. # 4427975) 
RNU-44 (Thermo Fisher Cat. # 4427975) 
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For primers utilized for mRNA qRT PCR see Table S1. 
Overlap with ISL1/LHX3 ChIP Seq 
To identify the genes regulated by LHX3 and ISL1 in motor neurons, ISL1- and LHX3-
ChIP sequencing data (Mazzoni et al., 2013) were used. We selected the regions co-occupied by 
ISL and LHX3 during ES to motor neuron differentiation, accounting for 84.2% of peak regions 
called in each ChIP-seq data. Based on the peaks co-occupied by ISL1 and LHX3, we annotated 
3,486 closest genes with peaks located within 5Kb upstream of TSS and intragenic regions. 
Comparing those annotated genes with genes selectively enriched in Moto-miNs vs miNs (log2 
fold change ≥ 2.5, p < 0.01), identified 323 genes co-occupied by ISL1 and LHX3 that are also 
upregulated when miR-9/9*-124 is co-expressed with ISL1/LHX3.  
Experimental Design 
For all experiments performed on miNs and Moto-miNs including molecular and 
functional characterizations of these cells, we do not specifically include or exclude samples or 
data. At minimum, biological duplicates were utilized for each experiment except DNA 
methylation profiling, where day 20 and day 30 conditions were treated as replicates to identify 
final DMRs. No statistical methods were used to predetermine sample size. Further specifics 
about the replicates (experimental n number) and performing procedures for each experiment are 
available in the Figure Legends and Star Methods. 
Analysis of converted cells 
The quantification of TUBB3, MAP2, NCAM and NEUN-positive cells over total 
number of cells (DAPI) shown in Figure 1C, Figure 6C, Figure S1F, and Figure S4C was done as 
follows: for TUBB3, MAP2, and NCAM only cells with processes at least three times the length 
of the soma were counted. For NEUN, only cells with proper nuclear localization were counted. 
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Figure 1C data are represented as mean ± SEM. N = number of cells analyzed in at least 6 
random fields of view from biological replicates. 22 Yr Female N = 238 cells, 42 Yr Female, N = 
100 cells, 56 Yr Male N = 171 cells, and 68 Yr Female N = 216 cells. Figure 6C data are 
represented as mean ± SEM. Cells (N) analyzed: 22 yr old N=TUBB3 325, MAP2 219, NCAM 
275; 42 yr old N=TUBB3 304, MAP2 236, NCAM 129; 56 yr old N=TUBB3 275, MAP2 279, 
NCAM 213; 68 yr old N=TUBB3 282, MAP2 234, NCAM 190. Quantification shown in Figure 
6E represents the total percentage of MNX1, CHAT and SMI-32-positive cells over TUBB3-
positive cells. Data are represented as mean ± SEM. Cells (N) analyzed: 22 yr old N=MNX1 
256, CHAT 256, SMI-32 113; 42 yr old N= MNX1 151, CHAT 151, SMI-32 283; 56 yr old N= 
MNX1 207, CHAT 207, SMI-32 174; 68 yr old N= MNX1 151, CHAT 151, SMI-32 96. Figure 
S1F data are represented as mean ± SEM. Cells (N) analyzed: Starting Fibroblasts N= DAPI 155, 
FSP1 155, MAP2 0; Day 9 N= DAPI 96, FSP1 26, MAP2 20; Day 12 N= DAPI 290, FSP1 106, 
MAP2 29; Day 15 N= DAPI 313, FSP1 88, MAP2 56; Day 18 N= DAPI 88, FSP1 27, MAP2 26; 
Day 21 N= DAPI 175, FSP1 31, MAP2 62; Day 24 N= DAPI 230, FSP1 27, MAP2 95; Day 27 
N= DAPI 290, FSP1 5, MAP2 143; Day 30 N= DAPI 203, FSP1 0, MAP2 155. Figure S4C data 
are represented as mean ± SEM. Cells (N) analyzed: Day 20 shBRG1 N= DAPI 155, FSP1 32, 
MAP2 11; Day 20 sh CTRL N= DAPI 173, FSP1 22, MAP2 117 
RNA-Seq data analyses  
More than 35 million reads of each RNA-seq sample were aligned to human genome 
assembly GRCh 37. For differential expression analysis, edgeR and limma were used. Genes 
with low read counts, regarded as genes not expressed at a biologically meaningful level were 
filtered out before read normalization. The cut-off for low read count was counts per million 
(CPM) < 1 in at least any two samples across the experiment. Reads for each sample were 
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normalized by the edgeR method of trimmed mean of M-values (TMM). The quantitative 
difference of read counts between miNs and starting fibroblast samples were evaluated by 
carrying out limma and graphically represented by Glimma. Gene enrichment analysis for 
differentially expressed genes was performed using Metascape Gene Annotation and Analysis 
Resource tool. 
For RNA-seq time series data in Figure 3, quality control, alignment, clustering, 
normalization, and expression comparison were performed by Cofactor Genomics 
(http://cofactorgenomics.com, Saint Louis, Missouri, USA). Raw sequence data in FASTQ 
format were assessed for quality (FastQC, 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and ribosomal RNA content 
(sortmeRNA, http://bioinfo.lifl.fr/RNA/sortmerna/). NovoAlign (Novocraft, 
http://novocraft.com) was used to align reads to a set of transcript sequences. NovoAlign 
parameters were set to allow multiple alignments to the transcriptome set to allow for isoforms. 
Alignments to the genome were performed using STAR (https://github.com/alexdobin/STAR). 
Only unique alignments to the genome were allowed. The genome alignment loci from all 
samples were combined and clustered to generate genomic loci (“patches”) with contiguous read 
coverage. Patches overlapping reference genome annotation loci were labelled as such. For each 
transcript or patch, the RPKM expression value was calculated for each sample. These RPKM 
values are the basis for expression comparison and statistics generation. For each replicate group, 
the mean and coefficient of variation for each transcript or patch were calculated across the 
expression values for the samples in that group. These means were considered to be the 
expression values for the replicate group. Adjusted P-values were calculated between the means 
of each pair of replicate groups using a Welch’s t-test corrected for fase discovery rate (FDR) by 
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the method of Benjamini-Hochberg. 
MicroArray analyses 
The intensity of the probes was imported into Partek and quantile normalized. 
Differentially expressed genes were identified using Partek with a cut-off of adjusted p-value < 
0.05 and over 2.5 log2 fold expression change. 
Quantitative-PCR analyses 
Expression data were normalized to housekeeping genes HPRT1 and RNU44 for coding 
genes and microRNAs, respectively, and analyzed using the 2-ΔΔCT relative quantification 
method. Data are represented as mean +/- S.E.M. from 3 biological replicates each individually 
performed in technical triplicates. For primers utilized for mRNA qRT PCR see Table S1. 
Differential DNA-methylated region analysis 
The M&M statistical model (Zhang et al., 2013), which integrates MeDIP-seq and MRE-
seq data to identify differentially methylated regions between two samples was implemented 
with a window size of 500 bp and a q-value (FDR-corrected P-value) cutoff of 5e-2. This cutoff 
was determined from Figure 3C, where only 1 DMR was detected at day 10 (miN day 10 vs. Ctrl 
day 10). For Figure 3B, only regions that were considered DMRs (q-value < 1e-5) at both day 20 
(miN day 20 vs. Ctrl day 20) and day 30 (miN day 30 vs. Ctrl day 30) are displayed. 
GO enrichment analyses 
DNA methylation GO analyses of MGI (Mouse Genome Informatics) expression (Smith 
et al., 2014) presented in Figure 3D were performed using the GREAT package (McLean et al., 
2010). Gene regulatory domains were defined by default as the regions spanning 5 kb upstream 
and 1 kb downstream of the TSS (regardless of other nearby genes). Gene regulatory domains 
were extended in both directions to the nearest gene’s basal domain, but no more than a 
maximum extension in one direction. The top 100 most significant overlapping DMRs from day 
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20 (miN day 20 vs. Ctrl day 20) and day 30 (miN day 30 vs. Ctrl day 30) were used as input. For 
Figure 3G, GO analyses were performed using Metascape (Tripathi et al., 2015) with a minimum 
enrichment of 1.5, a minimum overlap of 3, and a p-value cutoff of 0.01 using all demethylated 
or methylated DMRs at day 30 (miN day 30 vs. Ctrl day 30) that were either up- or down-
regulated, respectively, by RNA-seq at day 35 using a cutoff of 2.5 logFC.  
ATAC-Seq analyses 
More than 50 million ATAC-seq reads per sample were trimmed for Nextera adapter 
sequences using TrimGalore and aligned to hg19 human genome assembly using bowtie2 with 
parameters --very-sensitive --maxins 2000 --no-discordant –-no-mixed. Duplicate reads were 
discarded with Picard and uniquely mapped reads were used for downstream analysis. Peaks 
were called using Homer with parameters findPeaks -region -size 150 -minDist 300. Peaks called 
from all the samples were combined and raw reads mapped on the combined peaks were counted 
using HTSeq-count.  
Differential peaks between any two different samples of Ctrl day 10, miNs day 10, miNs 
day 20 were identified using edgeR with a cut-off of fold-change > 1.5 and FDR < 0.01. 
Differential peaks were regarded as peaks gained or lost at each time point. Gained peaks at 
miNs day 10 and day 20 were combined and defined as open chromatin regions. Conversely, all 
lost peaks at miNs day 10 and day 20 were defined as close chromatin regions. The genomic 
features in the differential open and closed chromatin regions were distributed by CEAS 
software (Shin et al., 2009). Differential peaks between shBRG1 day 20 and shEGFP day 20 
were defined using an independent cut-off (log2-fold-change ≥ 2, FDR < 0.05).  
We annotated Ref-seq genes nearest differential peaks with Homer annotatePeaks 
command. Based on the genomic distributions and peak annotations, we defined the promotor 
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regions (-/+ 2 kb from TSS) and distal regions (all peak positions except the promoter regions). 
GO enrichment analyses were performed by Metascape or the Gene Ontology. All heatmaps 
were made based on normalized signal intensity values (i.e. log2CPM) of each sample on 
relevant specific regions. 
All histone mark ChIP-seq data were obtained from Roadmap Epigenome database of 
human fibroblasts (Roadmap Epigenomics et al., 2015). To identify histone mark-occupied 
chromatin accessibility during reprogramming, we compared each histone ChIP-seq data with 
open and closed chromatin regions based on ATAC-seq. We confirmed that most open and 
closed chromatin peaks overlapped with histone mark-ChIP peaks were found outside promoter 
regions (+/- 2 kb from TSS). Open and closed chromatin regions excluding promoter regions 
were then compared with histone ChIP-seq data and analyzed for GO enrichment.  
Analysis of TRAP RNA-Seq data 
RNA-Seq reads were mapped to Ensembl release 76 using STAR (analysis performed 
by Genome Technology Access Center at Washington University in St. Louis).  For downstream 
analyses, only those genes with CPM > 1 in at least 3 samples, with an Ensembl gene biotype of 
"protein_coding," were retained. For gene symbols mapping to multiple Ensembl gene IDs, only 
the ID with the highest number of mapped reads was retained, resulting in a total of 14,009 genes 
used for downstream analyses. Using edgeR, read counts were fit to a negative binomial 
generalized log-linear model, and a likelihood ratio test was done to determine differential 
expression. 
Comparative analysis of RNA-seq and microarray data 
For comparative analysis, only probes with a detected call in at least 1 of 6 samples was 
retained, resulting in 23,775 probes mapping to a gene symbol. Expression level was then 
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averaged over all probes for each gene, resulting in a total of 15,333 genes that were used for 
comparative analysis, 10,736 of which were also present in the gene set retained from the RNA-
seq dataset (described above) after CPM filtering.  Within the genes retained in both datasets, the 
top differentially expressed genes between motor neurons and controls - CHAT IP vs. SNAP25 
IP (logFC > 1 and p < 0.05) in the RNA-seq dataset, and Moto-miN vs. miN (logFC > 2.5 and 
adjusted p < 0.05) in the microarray dataset - were assessed for significant contingency using a 
one-tailed Fisher's exact test.   
2.6 Data Availability 
The RNA-seq, ATAC-seq, MeDIP and MRE-seq, and microarray data generated in this 
study are: 14 samples, single-end RNA-seq libraries from starting fibroblasts and miNs 
throughout direct conversion (Days 3, 6 ,10, 20 and 30), 2 replicates per timepoint; 10 paired-end 
ATAC-seq libraries from day 10 Ctrl, day 10 and day 20 miNs, day 20 miNs with shBRG1 and 
day 20 miNs with an shCtrl, 2 replicates for each timepoint; 6 microarrays from starting 
fibroblasts, day 35 miNs, and day 35 moto-miNs, 2 replicates per condition; 6 samples of paired-
end MeDIP libraries and 6 samples of MRE single-end libraries from day 10, 20, 30 miNs and 
corresponding Ctrls. The GEO accession number for the RNA-seq, ATAC-seq, MeDIP and 
MRE-seq, and microarray data data reported in this paper is GSE102035. The GEO accession 
number for the TRAP-seq data is GSE93412 
.
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3.1 Methods 
3.1.1 LONGO algorithm and framework 
We developed LONGO, an R package that takes gene expression data from transcriptome 
experiments (e.g. RNA-seq or RNA microarray) as inputs from species represented on the 
ENSEMBL BioMart project (Smedley, et al., 2015). Figure 1 shows an overview of the LONGO 
algorithm using Rat BodyMap data (Yu, et al., 2014). The length of genes from the user-
specified species is calculated from gene start and stop positions, which are retrieved 
automatically using the biomaRt package (Durinck, et al., 2009). Gene-length dependent 
expression of samples is then calculated using a sliding window of genes sorted in ascending 
order by the length of the genes. LONGO quantile normalizes and filters input data (optional), 
calculates the median expression (or mean expression optionally) of genes binned by length 
(default genes per bin: 200), and then consecutively calculates the expression of the next bin 
(default step size: 40 genes). LONGO comes in two versions: one with a local HTML GUI for 
interactive work using the R Shiny package (LONGO) and one without a GUI for batch 
processing of data files (LONGOcmd). One strength of LONGO is provided through interactive 
plots—users have the option to modify parameters such as bin size, step size, sliding window 
mean or median, graph scales, as well as which samples are used as controls for downstream 
analyses. The significant difference of gene-length dependent expression is statistically tested by 
the Jensen-Shannon divergence (JSD) and the long gene quotient (LQ), which we develop 
herein. In addition, LONGO shows a plot of p-values generated using the Wilcox test comparing 
the binned gene expression values to the control. 
74 
 
 
Fig. 1. Illustration of LONGO output using Rat BodyMap data. 
RNA-seq of rat tissues from Rat BodyMap (Yu, et al., 2014): non-neuronal tissues (black) and 
brain tissues (red). (a) User inputs gene expression table into LONGO, which associates gene 
lengths with each gene. (b) LONGO calculates rolling median per user-defined parameters (For 
this figure: 200 gene bins, 40 gene step). (c) LONGO calculates partial increasing JSD from 
short genes to long genes between each sample and a user-defined control sample. (d) LONGO 
calculates a partial LQ (left) and final LQ (right). (e) LONGO identifies GO terms. 
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3.1.2 Measuring Jensen-Shannon Divergence 
The Kullback-Leibler divergence (KLD) is a non-commutative measure of the difference 
between two probability distributions P and Q, typically P representing the “true” distribution 
and Q representing an arbitrary probability distribution. One symmetrized and smoothed version 
of the KLD is the JSD (Endres and Schindelin, 2003), defined as 
 
 
 
where M = 0.5(P + Q) and the KLD is defined to be 
 
 
 
where , and the summation is taken over histogram bins. Therefore, for gene expression 
data ordered by gene length, we set P as the distribution from the control sample, and Q the 
distribution obtained from each of the testing samples. Smaller values of KLD represent more 
similar distributions. LONGO first measures the JSD for the shortest genes in two samples, then 
iteratively re-computes the JSD after adding the next longest until all genes in respective datasets 
have been added. The final JSD is the JSD between all expressed genes. 
3.1.3 Developing the long gene quotient 
To systematically discover disproportionately elevated long versus short gene expression 
between two samples, we adapted the JS divergence to generate the long gene quotient. LONGO 
first removes all genes whose gene length is less than the median gene length (typically ~30 kb) 
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for the dataset, which allows a clearer assessment of differences in long gene expression. Then 
LONGO calculates the partial LQ (PLQ) for any testing sample   ( ), which we define as 
 
 
 
where P represents the distribution of the control sample and D’JS only considers long 
genes (>150 kb). The PLQ describes the relative change in JSD of each sample compared with 
the maximum changes of JSD across all samples, so its magnitude ranges from 0 to 1. 
Because the underlying JSD does not distinguish the directionality of changes, we define 
the final LQ as LQ = S(PLQ), where S = -1 if mean(Q) < mean(P). This ensures that LQ is 
positive only if LGE is higher in the testing sample than in the control sample. The LQ is 
dependent on the control sample selected, as well as the sample with the most extensive LGE. 
Therefore, while LQ is effective at distinguishing neuronal from non-neuronal cells in the 
absence of a positive control, we strongly encourage including a positive control neuronal 
sample. The LQ is also dependent on the sliding window bin and step size; for the default of 200 
genes per bin with a 40 gene-step, using the median, neuronal cells typically exceed an LQ of 
0.25. 
In addition to LQ, the correlation between binned gene expression and median length of 
bins (default genes per bin: 200; default step size: 40 genes) for genes longer than 100 kb also 
identifies neuronal sample when highly positive (Fig. S1). Together with LQ, these metrics 
reliably distinguish neurons from non-neuronal samples. 
3.1.4 Gene ontology (GO) analysis 
Gene Ontology (GO) analysis allows understanding of the overall differences of gene 
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expression among multiple samples. This is accomplished by utilizing the GO database. The GO 
database contains information that links genes to GO terms. These GO terms can be broad, 
encompassing a large variety of biological functions, or narrow, including only a few specific 
functions. This allows the overall expression patterns of the genes to be categorized and then 
quantitatively measured. The hierarchies of GO terms provide an overview of the intersection of 
genes to biological functions. This intersection provides an insight into to the different cellular 
mechanisms by simplifying the data. One problem with using GO analysis is that as new 
information is discovered the genes for GO terms can be changed. Using an up-to-date database 
of GO terms can be used to avoid this problem but may lead to different results over time. Since 
the GO terms are determined by previous knowledge it can limit the potential to discover new 
features of genes. 
The LONGO package handles GO analysis by utilizing topGO (Alexa and Rahnenfuhrer, 
2016). LONGO allows multiple parameters in the GO analysis step. The main two are the 
statistical test and the method for graphing. The statistical test is used to determine the 
significance of the biological functions and the method for graphing is used to determine how the 
significant nodes should be graphed.  
3.1.5 Cellular reprogramming and analyses 
Human adult dermal fibroblasts from healthy individuals were acquired from the Coriell 
Institute for Medical Research: ND34769 (female, 68 years old at sampling; WT4) and AG04148 
(male, 56 years old; WT2). Cells were reprogrammed as described in Victor et al. (2014) using a 
lentiviral cocktail of rtTA, pTight-9-124-BclxL, CTIP2, MYT1L, DLX1, and DLX2. 
Immunocytochemistry was also performed as described in Victor et al. (2014) using primary 
antibody of rabbit anti-β-III tubulin (BioLegend, 1:2,000) and secondary antibody of anti-rabbit 
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IgG conjugated with Alexa-488 (Invitrogen, 1:1000). Images were captured using a Leica SP5X 
white light laser confocal system with Leica Application Suite Advanced Fluorescence 
2.7.3.9723. RNA-seq raw data was recently published (Victor et al., 2018). Briefly, RNA was 
extracted from converted neurons and isolated with TRIzol reagent (Thermo Fisher Scientific) 
per manufacturer’s instructions. After treating samples with Ribo-Zero kit (Illumina), cDNA 
library was sequenced in Illumina HiSeq 2500. Sequence reads were aligned to the human 
genome (hg38) with STAR v2.4.2a. Gene counts were derived from the number of uniquely 
aligned unambiguous reads by Subread:featureCount, version 1.4.6, with GENCODE gene 
annotation (V23).  
3.2 Results 
3.2.1 LGE identifies neurons upon differentiation and maturation during 
development 
To demonstrate LGE as an indicator of neuronal identity, we first analyzed RNA-seq 
gene expression profiles at the tissue level from the Rat BodyMap database (Yu, et al., 2014), 
which profiled 32 rats across 10 different organs (i.e. adrenal gland, brain, heart, kidney, liver, 
lung, muscle, spleen, thymus, and testis or uterus), using LONGO. Consistent with previous 
reports of LGE in brain tissues (Gabel, et al., 2015), we found that LONGO clearly distinguishes 
the brain from all other non-neuronal tissues with an LQ of 0.31 (Fig. 1b). Additionally, by 
measuring the collective levels of long gene expression, neuronal samples become readily 
identifiable in a population of non-neuronal samples without depending on the individual 
expression levels of known neuronal markers (Fig. S1). 
To further evaluate LGE in assessing post-mitotic neurons during neural development, 
we used LONGO to analyze transcriptome datasets collected from distinct regions of the 
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developing human cortex (Miller, et al., 2014). Interestingly, LGE analysis distinguished cortical 
and subcortical regions (i.e. intermediate zone, subcortical plate, cortical plate, subpial granular 
zone, and marginal zone; max LQ of 0.55) from other zones in which proliferative neural 
progenitors are prominent (i.e. ganglionic eminences, ventricular and sub-ventricular zones; max 
LQ of 0.13) (Fig. 2a). Our finding is consistent with the neuronal populations observed in 
cortical and subcortical regions (Miller, et al., 2014), and the increase in LGE likely reflects the 
number of differentiated neurons within each layer. To further pinpoint the cellular source of 
differential LGE, we analyzed LGE in different cell types isolated by fluorescence activated cell 
sorting (FACS) from the cortex (Zhang, et al., 2016), and found that only neurons displayed 
significantly enriched LGE in contrast to other cell types including astrocytes and 
oligodendrocytes, suggesting that increased LGE in whole cortex is likely due to neurons (Fig. 
S2a). Similarly, LGE analysis of single-cell RNA-seq of mouse visual cortex (Tasic, et al., 2016) 
identified increased LGE and LQ only for neurons, further validating LGE as a unique feature of 
neurons (Fig. 2b). Furthermore, by applying LONGO to data generated by Habib et al. (Habib, 
et al., 2016), where single-nucleus RNA-seq was combined with pulse-labeling of proliferating 
cells by EdU to track transcriptional dynamics of newborn neurons within the neurogenic niche 
of the adult hippocampus, we found that LGE increased as neural progenitor cells (NPCs) exited 
the cell cycle and continued to differentiate into neurons and mature in vivo (Fig. 2c), perfectly 
matching the maturation trajectory determined by Habib et al., and validating LGE as a reliable 
marker for post-mitotic mature neurons. In order to address whether increased LGE is also a 
feature of cultured neurons, we applied LONGO to the transcriptome data of motor neurons 
differentiated from mouse embryonic stem cells (ESCs) (Mahony, et al., 2011). Although minor 
differences in LGE were observed between embryoid body formation and induction of NPCs by 
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retinoic acid, the largest increase in LGE occurred when progenitors differentiated into post-
mitotic motor neurons (Fig. S2b). This finding is consistent with the notion that onset of LGE 
occurs during differentiation of NPCs to neurons, which is also apparent in tissue culture 
conditions. Together, our findings demonstrate LGE as a hallmark of neuronal development 
assayed at the single-cell and population levels.
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Fig. 2. LONGO output of neuronal differentiation and maturation during 
development. 
From left to right, reference for input data, rolling media of gene expression versus length (200 
gene bins, 40 gene step), partial LQ, and final LQ. (a) Layers of the developing human cortex 
(Miller, et al., 2014): ganglionic eminences (MGE, LGE, CGE; blue); ventricular zones (VZ and 
SVZ; black; and post-mitotic zones (SG, MZ, CP, SP, and IZ; red). (b) scRNA-seq neural cell 
subtypes from mouse visual cortex (Tasic, et al., 2016): glial cells (endothelial cells, microglia, 
astrocytes, oligodendrocytes, and OPCs) shown in black; neuronal subtypes (Th, Pvalb, L4, 
L2.3, L5, Chodl, Sst, Vip, Ndnf, and L6) shown in red. (c) Div-seq of adult newborn neurons in 
the neurogenic niche of mouse hippo-campus (Habib, et al., 2016): neural stem cells (NSCs), 
neural progenitor cells (NPCs), and neuroblasts (NBs) shown in black; immature neurons (IN) 
shown in red. Samples are numbered according to their maturity (Habib, et al., 2016). 
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3.2.2 LGE identifies neurons successfully reprogrammed from non-neuronal 
cells 
Based on the authenticity of LGE as a transcriptomic feature of neurons both in vivo and 
in tissue culture, we applied LONGO to evaluate cells generated by neuronal conversion using 
datasets from transcription factor-based (Colasante, et al., 2015; Treutlein, et al., 2016), 
microRNA-based (Victor, et al., 2014), and small molecule-based (Hu, et al., 2015) approaches 
to convert mouse or human fibroblasts to neurons. Because we routinely observe LQ exceeding 
0.25 in neurons (Fig. 2 and Fig. S3), we use this value as the threshold to indicate successful 
neuronal conversion. First, we used a transcriptome dataset in which neuronal conversion of 
mouse embryonic fibroblasts (MEFs) was monitored at a single cell level (Treutlein, et al., 2016) 
and applied LONGO to analyze differential LGE between successfully reprogrammed cells and 
cells that failed to convert (Fig. 3a). Only successfully converted neurons showed increased LGE 
and an LQ value substantially above 0.25, validating LGE analysis as a reliable approach to 
assess neuronal conversion. To test microRNA-based neuronal conversion (Victor, et al., 2014), 
we prepared RNA from an unpurified population of human striatal medium spiny neurons 
(MSNs) converted from fibroblasts and performed RNA-seq. When we applied LONGO to 
converted MSNs, we observed a dramatic increase in LGE similar to ESC-derived human 
neurons (Fig. 3b), despite that samples were unpurified. Furthermore, we find that LONGO 
detects variable conversion efficiencies inherent in different fibroblast samples—one fibroblast 
cell line (HAF2) that we previously found to display a lower conversion efficiency (Fig. S4) 
yielded an average LQ barely reaching 0.25, whereas the other 
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Fig. 3. LONGO output of somatic cell direct neuronal reprogramming. 
From left to right, reference for input data, rolling median of gene expression versus length (200 
gene bins, 40 gene step), partial LQ, and final LQ. (a) Direct reprogramming of mouse 
embryonic fibroblasts (MEFs) to neurons by transcription factors (Treutlein, et al., 2016): MEFs, 
myocytes, intermediate reprogramming (D2 and D5), and induced MEFs (D2) shown in black; 
failed reprogramming (D5 and D22) shown in purple; early (D5) and late (D22; dotted-line) 
successful reprogramming in red. (b) Direct reprogramming of human adult fibroblasts (HAFs) 
to striatal medium spiny neurons (MSNs) by microRNAs: HAFs from two different cell lines 
(black); MSNs derived from HAF2 (MSN2; purple); ESC-derived neurons(Gill, et al., 2016) 
(dotted-line) and MSNs derived from HAF1 (MSN1) shown in red. (c) Direct reprogramming of 
MEFs to iGABA by Foxg1, Sox2, Ascl1, Dlx5, and Lhx6 (Colasante, et al., 2015): MEFs 
(black); iGABA (dark purple); GAD67+ interneurons (red). 
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fibroblast cell line (HAF1) yielded an average LQ of 0.67 (Fig. 3b). 
Analysis of direct neuronal reprogramming of human fibroblasts by small molecules (Hu, 
et al., 2015) also revealed increased LGE approaching the levels obtained by ESC-derived 
neurons by prolonged treatment with small molecules (Fig. S5a). However, knockdown of 
PTBP1, which reportedly generates neuronal-like cells from HAFs (Xue, et al., 2016), does not 
increase LGE at the population level (Fig. S5b). Under these conditions, Xue et al. reported little 
expression of neuronal markers, such as MAP2 and NeuN, and the absence of neuronal electrical 
activity (Xue, et al., 2016), which is consistent with our finding of unaltered LGE. It will be 
interesting to apply LGE analysis to sequential knockdown of PTBP1 and PTBP2, which 
reportedly generated more functional neurons (Xue, et al., 2016). Finally, we analyzed RNA-seq 
data from MEFs overexpressing neuronal transcription factors Foxg1, Sox2, Ascl1, Dlx5, and 
Lhx6, which has been previously reported to generate GABAergic interneurons (Colasante, et 
al., 2015). Cells were purified by FACS based on the expression of GAD67, a marker for 
GABAergic interneurons, but were not electrically active at this time-point (Colassante et al. 
reported that cells became electrically active only after 4 weeks of co-culture with rat 
hippocampal neurons). Supporting LGE as a marker for mature neurons, we only detected 
increased LGE for control interneurons (GAD67), not for induced GABAergic interneurons 
(iGABA) in monoculture (Fig. 3c). 
3.2.3 GO analysis of neuronal differentiation 
GO enrichment analysis of mouse ESC differentiation to motor neurons in vitro 
(Mahony, et al., 2011) is shown in Fig. 4. The experiment has multiple GO terms identified as 
being significant. Rectangle color represents the relative significance, ranging from dark red 
(most significant) to bright yellow (least significant). The two lines show the GO identifier and a  
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Fig. 4. LONGO interactive GO analysis snapshot using incorporated topGO R 
package. 
Enrichment analysis of mouse ESC differentiation to motor neurons in vitro (Mahony, et al., 
2011). Rectangle color represents the relative significance, ranging from dark red (most 
significant) to bright yellow (least significant). The two lines show the GO identifier and a 
trimmed GO name. 
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trimmed GO name. 
The two categories identified are embryogenesis and neurogenesis. These results are in 
line with the source of the data set that was an experimental differentiation of embryonic stem 
cells to neurons. As the cells differentiate, the genes they express are altered providing the 
enriched GO terms. 
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3.3 Supplemental Figures 
 
Fig. S1. LGE identifies neuronal tissues, while PCA only separates tissues. 
(a) Principle components 1 and 2 of Rat BodyMap principle component analysis (PCA), with 
each sample colored by tissue of origin. (b) The same PCA as in (a), but now each sample is 
colored by the scaled correlation of binned gene expression (200 genes per bin; 40 genes per 
step) versus median gene length, here termed LGE. (c) Violin plot of the LGE values plotted in 
(b) for each Tissue. 
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Fig. S2. LONGO output of neuronal differentiation in vivo and in vitro. 
From left to right, reference for input data, rolling media of gene expression versus length (200 
gene bins, 40 gene step), partial LQ, and final LQ. (a) FACS sorted human neural cell subtypes 
(Zhang, et al., 2016): glial cells (oligodendrocytes, endothelial cells, S. astrocytes (sclerotic 
hippocampi astrocytes), G. astrocytes (GBM peri tumor astrocytes), F. astrocytes (fetal 
astrocytes), and M. astrocytes (mature astrocytes) shown in black; neurons and whole cortex 
(dotted-line) shown in red. (b) Mouse ESC differentiation to motor neurons in vitro (Mahony, et 
al., 2011): ESCs (D0), embryoid bodies (EBs; D2), and NPCs (D4) shown in black; motor 
neurons (D7) shown in red. In all analyzed data, LQ typically exceeds 0.25 in neurons. 
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Fig. S3. LQ cutoff of 0.25 stringently distinguishes neurons from non-neuronal 
cells. 
Percentage of samples that pass various LQ cutoffs from LQ data in Figures 2b,2c, and 2e for 
neuronal cells (red bar; n = 39) and non-neuronal cells (black bar; n = 40). 
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Fig. S4. Medium spiny neurons reprogrammed with miR-9/9*-124+CDM from 
fibroblasts of two unrelated adults shows variation in the proper acquisition of 
neuronal morphological features. 
(a) MSN1: Female, 68 years old at sampling - Coriell: ND34769 and (b) MSN2: Male, 56 years 
old - Coriell: AG04148, immunostained for TUBB3 in red and the nuclear stain DAPI in blue, at 
28 days post microRNA-based neuronal induction. In contrast to cells from HAF1 (MSN1), a 
large fraction of reprogrammed cells from HAF2 (MSN2) retains fibroblastic features such as 
expanded cell bodies and a large nucleus and have limited dendritic trees. Insets for each cell 
population display morphological characteristics in greater magnification. Our results 
demonstrate that TUBB3 immunostaining, a commonly used ‘neuronal marker’, does not 
reliably distinguish neurons from partially reprogrammed cells. 
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Fig. S5. LONGO output of small molecule and shPTBP1-induced 
reprogramming. 
From left to right, reference for input data, rolling median of gene expression versus length (200 
gene bins, 40 gene step), partial LQ, and final LQ. (a) Direct reprogramming of HAFs to neurons 
(Pre-hciN) by small molecules (Hu, et al., 2015): HAFs, Pre-hciN D3, and Pre-hciN D7 (dotted-
line) shown in black; hciN D14 and ESC-derived neurons (dotted-line) shown in red. (b)  Direct 
reprogramming of HAFs to neuron-like cells by shPTBP1 (Xue, et al., 2016): HAFs (black); 
shPTBP1 for 6 days (dark purple); shPTBP1 for 3 weeks (light purple). 
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4.1 Results 
4.1.1 Single-cell RNA-seq of microRNA-mediated reprogramming reveals a 
homogenous reprogramming trajectory 
To investigate the single-cell dynamics of miRNA-mediated neuronal reprogramming of 
human adult fibroblasts, we performed scRNA-seq along a time-series of reprogramming (Fig. 
1A and B). Of the 16,828 cells that passed filtering during analysis, most cluster by time point 
(Fig. 1C). As observed in other scRNA-seq experiments of reprogramming (Treutlein, et al., 
2016; Liu, et al., 2017), starting fibroblasts were heterogeneous, dividing into several distinct 
clusters (Fig. 1D and E). Remarkably, after day 10, virtually all cells converged onto a single 
reprogramming trajectory (Fig. 1D and E), which is consistent with previous reports of the high 
efficiency of miR-mediated reprogramming (Victor, et al., 2014; Abernathy, et al., 2017). Using 
quadratic programming, a comparison of these results with bulk transcriptome data from the 
same reprogramming conditions after day 35 (Abernathy, et al., 2017) corroborated a smooth and 
continuous reprogramming trajectory over time (Fig. 1F and G). Additionally, scRNA-seq 
identified common markers of fibroblasts and neurons (Fig. 1H and I), which have previously 
been demonstrated to decrease and increase, respectively, during reprogramming (Abernathy, et 
al., 2017). Together, these results demonstrate that miR-mediated direct reprogramming of 
human cells into neurons is highly efficient, with heterogenous starting fibroblasts converging 
onto a homogenous reprogramming trajectory. 
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Fig. 1. Direct conversion of human adult fibroblasts yields a homogenous 
population of neurons. 
(A) Schematic of microRNA-mediated motor neuron reprogramming and sample collection. 
Starting human adult fibroblasts (Day 0) were collected, followed by periodic collection of cells 
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after induction of reprogramming (Day 5, 10, 15, and 20). (B) Adult human fibroblasts 
ectopically expressing miR-9/9*-124 with ILS1 and LHX3 for 35 days immunostained for the 
early pan-neuronal marker TUBB3, and motor neurons markers MNX1 and CHAT. The insets 
represent starting fibroblasts co-stained as negative Controls. Scale bars, 20 mm. (C to I) 
scRNA-seq analysis of reprogramming. (C)  t-SNE projection of single cells, colored according 
to time point. Total cells at each time point: 4360 (Day 0), 7083 (Day 5), 3031 (Day 10), 1760 
(Day 15), and 585 (Day 20). (D) t-SNE projection of single cells, colored by unsupervised 
clustering based on specific and distinct gene expression profiles. (E) Bar plot of cells per cluster 
per time point as a fraction of the total number of cells at each time point. (F) t-SNE projection 
of single cells, colored by quadratic programming scores based on overall similarity to day 35 
bulk transcriptome analysis of reprogrammed motor neurons (raw data from Abernathy, et al., 
2017). (G) Density plot of quadratic programming scores, colored by time point. (H) t-SNE 
projection of single cells (same axes as in previous t-SNE plots), colored by expression of 
fibroblast marker genes (top) and neuron marker genes (bottom). (I) Violin plot quantification of 
gene expression from (H). 
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4.1.2 Long gene expression distinguishes mature from immature neuronal 
gene expression 
Previously, we reported on the extensive epigenetic and transcriptomic remodeling that 
occurs early during neuronal reprogramming, which broadly reflects aspects of neurogenesis in 
vivo (Abernathy, et al., 2017). Here, we characterized the single-cell dynamics of neuronal 
maturation during the late stages of reprogramming. In part because single-cell RNA-seq suffers 
from high rates of drop-out resulting in unreliable measurement of individual gene expression, 
we turned to an analysis we previously developed that measures the collective expression of the 
top 10% of the longest genes in the genome, which we have termed Long Gene Expression [LGE 
(McCoy, et al., in press)]. Since LGE is specific to neurons and increases with the time since the  
last cellular division as a neural progenitor in vivo (McCoy, et al., in press), we sought to 
determine if LGE could be used to assess the maturity of reprogrammed neurons. We found that 
LGE could be detected at the single-cell level and increased over time during reprogramming 
(Fig. 2A-C). Additionally, the onset of LGE mirrored activation of mature neuronal markers (e.g. 
MAP2 and SNAP25) and occurred after the transient upregulation of genes typically enriched in 
late neural progenitors and immature neurons in vivo (e.g. GFAP and NES; Fig. 2D and E). LGE 
scores correlated with neuronal marker (e.g. MAP2) expression and anticorrelated with late 
progenitor and immature neuronal marker (e.g. GFAP) expression. (Fig. 2F). Expression of 
neuronal BAF (nBAF) chromatin remodeling complex subunits (e.g. ACTL6B/BAF53b and 
DPF3/BAF45c) were also observed in conjunction with the downregulation of the neural 
progenitor BAF (npBAF) complex subunits (e.g. ACTL6A/BAF53a and PHF10/BAF45a; Fig. 
2D and E; fig. S1). This same subunit switching is observed in vivo upon differentiation of 
neurons from neural progenitor cells, a process which, significantly, is controlled by the 
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expression of miR-9/9* and miR-124 in vertebrates (Yoo, et al., 2009). This data shows that later 
stages of human neuronal reprogramming mirror important aspects of neuronal maturation in 
vivo and demonstrates that LGE is a transcriptomic feature that distinguishes mature neurons 
from immature neurons. 
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Fig. 2. Long gene expression distinguishes mature from immature neurons. 
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(A) Median gene expression of genes binned according to gene length (200 genes per bin, 40 
genes per step). Confidence limits for the population means based on basic nonparametric 
bootstrapping are shown as a transparent ribbon for each time point. Vertical dashed line shows 
100 kb. (B) t-SNE projection of single cells, colored by LGE scores (correlation of gene 
expression versus length of the top 10% longest genes in the human genome). (C) Violin plot of 
LGE scores for each time point. (D) Expression heatmap of representative late 
progenitor/immature neuron markers (RPN2, BCAN, GFAP, CALB2, NES, SOX3, 
ACTL6A/BAF53a) and mature neuron markers (ACTL6B/BAF53b, LMO1, MNX1, SNAP25, 
MAP2) for day 15 and day 20 cells. Cells are ordered based on quadratic programming scores, 
with the most neuronal cells on the right. LGE scores and time point are shown for each cell. (E) 
(Top) Generalized additive models for the expression of late progenitor/immature neuron 
markers (CALB2 and GFAP in blues), mature neuron markers (MAP2 and ACTL6B/BAF53b in 
reds), and LGE (purple) versus quadratic programming scores for all cells of every time point. 
(Bottom) Density plot of quadratic programming scores for all cells colored by time point. Light 
blue box indicates day 15 and 20 cells visualized in (D). (F) The first two principle components 
of a principle component analysis are compared against LGE using day 15 and day 20 
reprogrammed neurons, with individual cells colored by time point (left column), MAP2 
expression (middle column), and GFAP expression (right column). 
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4.1.3 BRG1 inhibition reduces LGE 
BAF53b and the nBAF complex are essential for the highly conserved program of post-
mitotic neural development and dendritic morphogenesis (Wu, et al., 2007; Parrish, et al., 2006).  
Since initiation of neuronal maturation during direct reprogramming corresponded with the 
switching of BAF subunits at day 20 (Fig. 2D), we predicted that functional BAF complex is 
necessary for neuronal maturation in reprogramming. To test this, we knocked down 
SMARCA4/BRG1, a core component of the BAF complex, during direct reprogramming. At day 
20, we performed RNA-seq and found that LGE was significantly downregulated by BRG1 
knockdown (Fig. 3). Furthermore, the switching of immature to mature gene expression patterns 
demonstrated in Figure 2 was not observed in BRG1 knockdown condition (fig. S2). These 
results are consistent with our previous findings that BRG1 knockdown reduces the number of 
MAP2-positive cells at day 20 of reprogramming, while also reducing chromatin accessibility of 
loci important for reprogramming (Abernathy, et al., 2017). 
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Fig. 3. Functional neuronal BAF complex is necessary for LGE. 
Knockdown of BRG1 by shRNA (shBRG1; red) or control shRNA (shCTRL; blue) concurrent 
with microRNA-mediated reprogramming assayed by RNA-seq at day 20. (A) Median gene 
expression of genes binned according to gene length (200 genes per bin, 40 genes per step). 
Confidence limits for the population means based on basic nonparametric bootstrapping are 
shown as a transparent ribbon for each time point. (B) Same plot as for (A) but only with largest 
10% of genes in the human genome. (C) Mean scaled correlation of gene expression versus 
length for top 10% of genes in the human genome. Error bars represent standard error of mean. 
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4.1.4 Inhibiting LGE reduces spontaneous activity 
Previous studies have suggested the importance of long genes in normal neuronal 
development and have identified certain long genes and the pathways that regulate them (e.g. 
TOP1) to be mutated in several neurological disorders, such as autism spectrum disorder and 
Rett syndrome (King, et al., 2013; Gabel, et al., 2015). It is also known that many long genes can 
be artificially downregulated through inhibition of topoisomerase I (TOP1) activity, which 
decreases the surface expression of corresponding synaptic proteins, and thereby decreases 
electrical activity (Mabb, et al., 2014). Here, we treated primary rat cortical neurons with the 
TOP1 inhibitor, Topotecan, measured electrophysiological properties, then performed bulk 
RNA-seq. Consistent with previous reports, we found that treatment with Topotecan 
downregulated LGE and decreased spontaneous electrical activity without disrupting neuronal 
cell fate, as indicated by grossly normal neuronal morphology and neuronal marker expression 
(Fig. 4). These results are particularly interesting since the BAF complex has been implicated in 
recruitment of TOP1 to chromatin (Husain, et al., 2016); this association could help explain the 
preferential downregulation of long genes by TOP1 inhibition as well as by  knockdown of BAF 
complex subunits. 
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Fig. 4. Inhibition of long gene expression reduces spontaneous electrical 
activity of mature neurons. 
(A) Map2 immunocytochemistry of primary rat cortical neurons treated with DMSO control 
(left) or TOP1 inhibitor, topotecan (TOPO; right) for 72 hours. (B) Median gene expression of 
genes binned according to length (200 genes per bin, 40 genes per step) for the top 10% longest 
genes in the rat genome. Top and bottom ribbon (dark lines) show confidence limits for the 
population means based on basic nonparametric bootstrapping. (C) Correlation values for gene 
expression versus length of the top 10% longest genes in the rat genome. (D) Log10 expression 
of two neuronal genes (Actl6b and Map2) and two non-neuronal genes (Col13a1 and S100a4). 
(E) Phase contrast microscopy image of primary rat cortical neurons plates onto a microelectrode 
array (MEA). (F) Exemplary electrophysiological measurements obtained from MEA recording 
over a 10-minute period. (G) -Log10 p-values for several electrophysiological measurements 
obtained from MEA recording. 
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4.2 Supplemental Figures 
 
Fig. S1. PHF10/BAF45a to DPF3/BAF45c BAF complex subunit switching 
during neuronal reprogramming. 
(A) t-SNE projection of single-cells, colored by PHF10 expression (top) and DPF3 expression 
(bottom). (B) Violin plots quantifying PHF10 expression (top) and DPF3 expression (bottom) at 
each time point during reprogramming. 
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Fig. S2. Inhibition of BRG1 expression impairs maturation of reprogramming 
neurons. 
RNA-seq analysis of microRNA-mediated reprogramming of human adult fibroblasts into 
neurons with Brg1 knockdown, with immature neuronal markers (NES and RPN2), neural 
progenitor BAF complex subunit (PHF10), fibroblast marker (S100A4), neuronal markers 
(POU3F2, NRXN1, and DCC), and neuronal BAF complex subunit (DPF3). 
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4.3 Materials and Methods 
Direct Conversion and Cell Collection 
Primary 22 year old female adult human fibroblasts (NIGMS, GM02171) were seeded 
onto Costar 6 well cell culture vessels (Corning) at a density of 300,000 cells/well. The 
following day, each plate was transduced with the following reprogramming cocktail: 750 uL of 
concentrated lentivirus containing the reverse tetracycline-controlled transactivator (rtTA; 
Addgene, 66810), 500 μL of virus containing pT-BCL-9/9*-124 (Addgene, 60859), and 500 uL 
of each virus containing Lhx3 and Isl1 under the control of the EF1 promoter in the presence of 
polybrene (8 μg/mL ; Sigma-Aldrich) all diluted up to 18 mL with MEF media. 3 mLs of the 
virus/media solution was added to each well then spinfected at 37C for 30 minutes at 1,000xG 
using a swinging bucket rotor.  
One day post-transduction media was changed to fresh fibroblast media (2 mL per well) 
supplemented with doxycycline (Dox; Sigma Aldrich, 1 μg/mL). After 2 days, fresh fibroblast 
media was changed and supplemented with Dox and antibiotics for respective vectors 
(Puromycin, 3 μg/ml; Geneticin, 400 ug/mL; all from Invitrogen). Five days post-transduction 
cells were replated on to poly-ornithine/laminin/fibrobnectin (PLF) coated glass coverslips. 
Before PLF coating, glass coverslips were acid treated according to (Richner et al., 2015). To 
transfer cells, for each well of a 6 well plate, cells were first washed 2x with 1 mL sterile PBS. 
Then 320 μL of 0.25% Trypsin (Gibco) was added to each well then placed in an incubator. Cells 
were monitored every 2 minutes, as soon as cells began to detach (no more than 6 minutes) 1 ml 
of MEF media supplemented with 1 μg/mL Dox was added to each well. One by one, each well 
was gently triturated three times to remove remaining attached cells then transferred to a sterile 
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1.5 mL Eppendorf tube. Cells were then spun at 200xG for 5 minutes at 37C. The supernatant 
was aspirated and cells were gently resuspended in 300 μL MEF media supplemented with Dox. 
Cells were then drop-plated onto 12mm (60 μL per c.s.; placed in 24 well plate) coverslips. Cells 
were left to settle for 15 minutes in an incubator then each well was flooded with MEF media 
supplemented with 1 μg/mL Dox. The following day media was then changed to Neuronal Media 
(Sciencell) supplemented with Dox, valproic acid (1 mM; EMD Millipore) dibutyryl cAMP (200 
μM; Sigma-Aldrich), BDNF, NT-3, CNTF, GDNF (all 10 ng/ml, Peprotech), and Retinoic Acid 
(1 uM; Sigma-Aldrich) and antibiotics for each vector. Dox was replenished every two days and 
half the media was changed every 4 days. Drug selection was halted 14 days into conversion. At 
0, 5, 10, 15 and 20 days into reprogramming, media was aspirated out of 2 wells containing cells 
being converted, then these cells were washed with 500uL of sterile PBS and then 200uL of 
.25% Trypsin was added to each well. Cells were closely monitored and upon detachment from 
the culture vessel. Upon detachment each well was flooded with complete neuronal media 
supplemented with 5% FBS. Cells were then counted using a hemocytometer followed 
centrifugation at 200xG for 5 minutes at 37C. Cell pellets were finally resuspended in Cryostar 
CS10 cryopreservation medium (StemCell Technologies, #07955) at a concentration of 100 cells 
per uL and 100 uL aliquots were placed in a cryogenic freezing container (ThermoFisher 
Scientific, # 5100-0001) and stored at -80C until all timepoints were collected.  
 
RNA-seq data acquisition, quality control, and processing for primary rat cortical neurons 
treated with topotecan 
RNA-seq reads were aligned to the Ensembl release 76 top-level assembly with STAR 
version 2.0.4b.  Gene counts were derived from the number of uniquely aligned unambiguous 
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reads by Subread:featureCount version 1.4.5.  Transcript counts were produced by Sailfish 
version 0.6.3.  Sequencing performance was assessed for total number of aligned reads, total 
number of uniquely aligned reads, genes and transcripts detected, ribosomal fraction known 
junction saturation and read distribution over known gene models with RSeQC version 2.3. 
All gene-level and transcript counts were then imported into the R/Bioconductor package 
EdgeR and TMM normalization size factors were calculated to adjust samples for differences in 
library size.  Genes or transcripts not expressed in any sample or less than one count-per-million 
in the minimum group size minus one were excluded from further analysis.  The TMM size 
factors and the matrix of counts were then imported into R/Bioconductor package Limma and 
weighted likelihoods based on the observed mean-variance relationship of every gene/transcript 
and sample were then calculated for all samples with the voomWithQualityWeights function.  
Performance of the samples was assessed with a spearman correlation matrix and multi-
dimensional scaling plots.  Gene/transcript performance was assessed with plots of residual 
standard deviation of every gene to their average log-count with a robustly fitted trend line of the 
residuals. Generalized linear models were then created to test for gene/transcript level 
differential expression. Differentially expressed genes and transcripts were then filtered for FDR 
adjusted p-values less than or equal to 0.05. 
To enhance the biological interpretation of the large set of transcripts, grouping of 
genes/transcripts based on functional similarity was achieved using the R/Bioconductor packages 
GAGE and Pathview. GAGE and Pathview were also used to generate pathway maps on known 
signaling and metabolism pathways curated by KEGG. 
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5.1 Molecular Mechanisms of MicroRNA-Mediated 
Reprogramming 
MiRNA-mediated neuronal conversion appears to be distinct from current models of cell 
fate reprogramming. Two models of lineage reprogramming have been proposed: one based on 
transcription factor cooperativity and positive feedback loops (Jaenisch and Young, 2008; Soufi 
et al., 2012; Vierbuchen and Wernig, 2012), and the other based on the “on-target” pioneer 
activity of a TF as shown in neuronal conversion of mouse embryonic fibroblasts (Wapinski et 
al., 2013). In contrast, canonical gene regulation by miRNAs presumably utilizes the removal of 
gene products through translational repression and transcript degradation for the target genes. 
This mode of repression, in conjunction with the multitude of anti-neurogenic genes targeted by 
miR-9/9*-124, suggests that miRNA-mediated reprogramming acts through an alternative 
mechanism. We propose miR-9/9*-124 expression in non-neuronal somatic cells initiates 
gradual, yet active changes in the activities of multiple chromatin modifiers while 
simultaneously repressing anti-neuronal genes and activating neuronal genes culminating in a 
binary cell-fate switch. This model is supported by the rapid cell cycle exit observed upon 
ectopic miR-9/9*-124 expression, the subsequent neuronal switching among chromatin 
modifiers, steady increase in epigenetic and transcriptional changes, and the time scale in which 
conversion takes place. 
5.1.1 Chromatin Remodeling Accompanies Cell Fate Conversion 
In this study, we reveal the surprising potency of miR-9/9*-124 for remodeling chromatin 
and altering DNA methylation. Surprisingly, preexisting neuronal loci within the 
heterochromatic regions in human fibroblasts opened in response to miR-9/9*-124. These data 
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suggest that the robustness of miRNA-mediated reprogramming observed in human adult 
fibroblasts could stem from the ability of these miRNAs to induce epigenetic changes. Cellular 
processes and identity are governed by the cumulative action of multiple levels of genome 
regulation, and it is unlikely that a single genetic component downstream of miR-9/9*-124 
would mediate such drastic changes in cellular identities. For example, almost every level of 
epigenetic remodeling participates in the induction of pluripotency (Takahashi and Yamanaka, 
2016), and instructions operating through multiple levels of genetic and epigenetic regulation are 
likely required for true cell-fate conversion. As such, our thorough analyses of miR-9/9*-124 
induced transdifferentiation of human fibroblasts into functional neurons highlights molecular 
processes that are critical to cell fate conversion. 
5.1.2 A Modular Neuronal State 
The miRNA-mediated neuronal platform presented here affords modularity to direct the 
conversion to specific neuronal subtypes. Numerous studies in developmental neuroscience have 
identified subtype-specific TFs or terminal selector genes that could be incorporated in neuronal 
reprogramming technologies. Yet, identifying molecules capable of overcoming the cell-fate 
barrier present in human somatic cells and eliciting a permissive environment in which terminal 
selector genes can act has proven to be challenging. In this study, we demonstrate that miR-9/9*-
124 are capable of evoking a neuronal state through extensive epigenetic remodeling that can 
lead to generation of a neuronal population highly enriched with spinal cord motor neurons on 
addition of ISL1 and LHX3. Because motor neurons are the major neuronal subtype affected in 
Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA), the robustness and 
specificity of neuronal conversion employing miRNAs and motor neuron TFs may pave the way 
towards generating patient-specific MNs for disease modeling.  
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5.2 Long Gene Expression Identifies Neurons 
5.2.1 LONGO is a Computation Tool that Measures LGE to Identify Neurons 
As interest in modeling neuronal cell fate acquisition and modeling neurological diseases 
using reprogrammed neurons continues to grow, so does the need to validate and improve 
methodologies for neuronal reprogramming. Toward this end, we have developed a method to 
identify neurons from non-neuronal cells based on the collective expression of the longest genes 
in the genome. By incorporating this method into an R computation package, LONGO, we hope 
to facilitate this analysis for other researchers. 
For investigators interested in adopting an existing reprogramming technique in their 
research programs, LONGO provides a metric for evaluating the efficiency of different 
techniques. The robustness of LGE analysis provided by LONGO and the steadily declining cost 
of transcriptome analyses lead us to strongly advise investigators who perform neuronal 
reprogramming or differentiation to routinely generate transcriptome data and analyze LGE to 
confirm neuronal identity. 
One of the known correlates of gene length is the levels of alternative splicing (McGuire 
et al., 2008), which is a feature also enriched in vertebrate and invertebrate nervous systems 
(Barbosa-Morais et al., 2012; Jelen et al., 2007; Merkin et al., 2012). Some of these long genes 
encode over 20,000 different protein isoforms, and are uniquely expressed in individual neurons, 
endowing each neuron with a unique molecular profile (Miura et al., 2013). So, while each 
neuron expresses copies of long genes, these copies are not identical to even those from 
neighboring neurons of the same tissue. Our method allows us to measure the expression of long 
genes collectively to determine if a cell or tissue is neuronal, but does not typically provide the 
resolution to determine differences between one type of neuron versus another, or one type of 
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neural tissue versus another. 
5.2.2 Long Gene Expression Distinguishes Mature from Immature Neurons 
By performing single-cell RNA-seq during microRNA-mediated neuronal 
reprogramming, I discovered that this process results in a surprisingly homogenous 
reprogramming trajectory. Beyond demonstrating the robustness of microRNA-mediated 
neuronal reprogramming, I discovered that LGE can be applied at the single-cell level, and 
successfully identifies reprogrammed neurons. After the transient upregulation of immature 
neuron gene expression, LGE continues to increase alongside mature neuron gene expression 
and acquisition of spontaneous electrical activity. One of the markers of mature neuronal gene 
expression patterns is subunit switching from the neural progenitor BAF to the neuronal BAF 
complex, which we observe during neuronal reprogramming. On disrupting the functional BAF 
complex during reprogramming, we find that LGE is decreased, as is the acquisition of neuronal 
marker expression. The close relationship between LGE onset and subunit switching of the BAF 
complex provides insight into the gene expression programs initiated during neuronal 
maturation, and suggests that gene length plays an important role in the evolution and/or 
regulation of these programs in the nervous system. Particularly since the BAF complex is 
deeply conserved, determining the conservation of LGE may provide important insights into the 
evolution of the nervous system. Further, by disrupting LGE via TOP1 inhibition, we show that 
LGE is necessary for spontaneous electrical activity in mature neurons. We propose that LGE is 
a cumulative measure of the synaptic and adhesion molecules necessary for the 
electrophysiological properties of mature neurons. 
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